<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//www.pharmaceutical-business-review.com/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6948fpervasis_therapeutics_wins_orphan_drug_designation_for_vas-2/</loc>
		<lastmod>2009-05-06T10:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/384b9zoll_medical_completes_purchase_of_assets_from_a-2/</loc>
		<lastmod>2009-05-06T10:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dc4b3acelrx_initiates_phase_ii_pain_-2/</loc>
		<lastmod>2009-05-06T10:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a94b0svelte_medical_systems_signs_licensing_agreement_with_c-2/</loc>
		<lastmod>2009-05-06T10:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a3489takeda_global_rd_center_names_new_pres-2/</loc>
		<lastmod>2009-05-06T10:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6a484ocimum_biosolutions_launches_affymetrix_services_in_e-2/</loc>
		<lastmod>2009-05-06T10:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/504b5oxfordemergent_tuberculosis_consortium_signs_licensing_agreement_with_vi-2/</loc>
		<lastmod>2009-05-06T10:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/be484oxfordemergent_consortium_signs_licensing_agreement_with_probioge-2/</loc>
		<lastmod>2009-05-06T11:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1d49fnovagali_pharmas_ind_for_glaucoma_drug_wins_fda_clea-2/</loc>
		<lastmod>2009-05-06T11:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/de4baacordas_nda_for_multiple_sclerosis_drug_accepted_for_filing_b-2/</loc>
		<lastmod>2009-05-06T11:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4848cbioject_signs_crada_with_us_navy_for_malaria_va-2/</loc>
		<lastmod>2009-05-06T11:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/encouraging_signs_in_swine_flu_outbreak_060509-2/</loc>
		<lastmod>2009-05-06T11:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cambrex_first_quarter_2009_net_income_increases_to_47m_060509-2/</loc>
		<lastmod>2009-05-06T12:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nanosphere_posts_net_loss_of_81_million_in_q1_2009_090507-2/</loc>
		<lastmod>2009-05-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alexza_posts_total_operating_expenses_of_163_million_for_q1_2009_090507-3/</loc>
		<lastmod>2009-05-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/millipore_posts_revenues_of_4079_million_for_q1_2009_090507-3/</loc>
		<lastmod>2009-05-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vical_posts_net_loss_of_82_million_in_q1_2009_090507-3/</loc>
		<lastmod>2009-05-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d24admerck_serono_launches_glucophage_powder_in_france_a-2/</loc>
		<lastmod>2009-05-07T06:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f249cillumina_files_patent_infringement_lawsuit_against_affym-2/</loc>
		<lastmod>2009-05-07T07:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1649cponiard_wins_positive_review_for_phase_iii_lung_cancer_-2/</loc>
		<lastmod>2009-05-07T07:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cd498aperio_opens_new_subsidiary_in_-2/</loc>
		<lastmod>2009-05-07T07:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/09483invitrogen_develops_new_stem_cell_techn-2/</loc>
		<lastmod>2009-05-07T07:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fe4aevertex_appoints_new_global_rd_-2/</loc>
		<lastmod>2009-05-07T07:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b34afnabsys_raises_4_million_in_equity_fina-2/</loc>
		<lastmod>2009-05-07T07:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5c49facorda_therapeutics_q1_net_loss_w-2/</loc>
		<lastmod>2009-05-07T07:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/364b0charles_river_laboratories_q1_net_income_decr-2/</loc>
		<lastmod>2009-05-07T07:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0648fsimcere_seeks_approval_to_manufacture_and_sell_influenza-2/</loc>
		<lastmod>2009-05-07T07:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c34b2ingenuity_systems_signs_multiyear_agreement_with_astraz-2/</loc>
		<lastmod>2009-05-07T09:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/il_wins_patent_infringement_lawsuit_against_diagnostica_stago_070509-2/</loc>
		<lastmod>2009-05-07T11:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genentech_wins_fda_approval_for_new_indication_of_avastin_070509-2/</loc>
		<lastmod>2009-05-07T11:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/heat_biologics_gains_irb_approval_to_expand_phase_i_cancer_vaccine_study_070509-2/</loc>
		<lastmod>2009-05-07T12:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eclipsys_releases_influenza_a_h1n1_outcomes_toolkit_070509-2/</loc>
		<lastmod>2009-05-07T12:59:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/jubilants_us_subsidiary_wins_fda_approval_for_generic_sestamibi_070509-2/</loc>
		<lastmod>2009-05-07T13:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/rexahn_reports_positive_preliminary_results_from_phase_iia_ed_trial_070509-2/</loc>
		<lastmod>2009-05-07T13:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/teva_q1_net_income_surges_to_451m_070509-2/</loc>
		<lastmod>2009-05-07T14:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/calistoga_pharmaceuticals_secures_30m_in_series_b_financing_070509-2/</loc>
		<lastmod>2009-05-07T14:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/niti_surgical_introduces_colonring_surgical_device_070509-2/</loc>
		<lastmod>2009-05-07T15:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novavax_initiates_enrollment_in_second_phase_ii_influenza_vaccine_trial_070509-2/</loc>
		<lastmod>2009-05-07T16:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/myriad_genetics_reports_q3_net_profit_070509-2/</loc>
		<lastmod>2009-05-07T17:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/basilea_wins_spanish_approval_for_chronic_hand_eczema_drug_070509-2/</loc>
		<lastmod>2009-05-07T17:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/misonix_signs_five_year_distribution_agreement_with_ekrior_for_portugal_090508-2/</loc>
		<lastmod>2009-05-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c4489ark_granted_fast_track_status_for_t-2/</loc>
		<lastmod>2009-05-08T01:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8348csummit_divests_zebrafish_services_business_to_e-2/</loc>
		<lastmod>2009-05-08T01:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/074a6vernalis_and_servier_form_oncology_collabor-2/</loc>
		<lastmod>2009-05-08T02:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b24a5lipoxen_reports_positive_results_from_phase_i_epo_-2/</loc>
		<lastmod>2009-05-08T02:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b848dimpax_wins_final_fda_approval_for_generic_depakote_ta-2/</loc>
		<lastmod>2009-05-08T02:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e3483cardium_completes_patient_recruitment_in_phase_iib_diabetic_foot_ulcers_-2/</loc>
		<lastmod>2009-05-08T02:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ad491vanda_wins_fda_marketing_approval_for_schizophrenia-2/</loc>
		<lastmod>2009-05-08T02:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fb492bioelectronics_concludes_menstrual_pain_-2/</loc>
		<lastmod>2009-05-08T02:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/824bdmedtronic_wins_fda_approval_for_new_implantable_cardiac_d-2/</loc>
		<lastmod>2009-05-08T03:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7e484endocyte_initiates_phase_i_study_of_tumor-2/</loc>
		<lastmod>2009-05-08T04:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c248cdpharm_files_ind_and_spa_for_phase_iii_stroke_-2/</loc>
		<lastmod>2009-05-08T04:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ec4bearchemix_names_new_president_an-2/</loc>
		<lastmod>2009-05-08T04:20:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c9489vaxinnate_raises_30_million_in_series_d_fina-2/</loc>
		<lastmod>2009-05-08T04:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/64494sanofi_pasteur_wins_fda_license_for_new_flu_vaccine_fac-2/</loc>
		<lastmod>2009-05-08T04:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/clarient_introduces_new_breast_cancer_test_080509-2/</loc>
		<lastmod>2009-05-08T05:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/evoke_pharma_initiates_phase_iib_diabetic_gastroparesis_trial_080509-2/</loc>
		<lastmod>2009-05-08T06:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gene_network_sciences_wins_new_us_patent_070509-2/</loc>
		<lastmod>2009-05-08T06:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/system_c_healthcare_acquires_bluestar_uk_group_070509-2/</loc>
		<lastmod>2009-05-08T07:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sequella_initiates_dosing_in_phase_ib_tuberculosis_trial_080509-2/</loc>
		<lastmod>2009-05-08T08:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/supergen_reports_positive_data_from_phase_ib_lung_cancer_study_080509-2/</loc>
		<lastmod>2009-05-08T08:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis_wins_eu_approval_for_gastro_tumor_drug_080509-2/</loc>
		<lastmod>2009-05-08T09:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lux_biosciences_reports_positive_results_from_phase_iii_uveitis_program_080509-2/</loc>
		<lastmod>2009-05-08T10:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lcp_reports_positive_interim_results_from_phase_ii_kidney_transplant_trial_080509-2/</loc>
		<lastmod>2009-05-08T12:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/potentia_completes_phase_i_age_related_macular_degeneration_trial_080509-2/</loc>
		<lastmod>2009-05-08T12:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/instrumentation_laboratory_wins_fda_clearance_for_new_hemostasis_testing_system_080509-2/</loc>
		<lastmod>2009-05-08T12:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biovail_acquires_us_marketing_rights_to_depression_drug_from_gsk_080509-2/</loc>
		<lastmod>2009-05-08T13:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cytori_posts_product_revenues_of_19_million_for_q1_2009_090511-2/</loc>
		<lastmod>2009-05-10T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/misonix_posts_8_million_revenues_for_q3_fiscal_2009_090511-2/</loc>
		<lastmod>2009-05-10T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amarin_wins_fda_agreement_on_phase_iii_cardiovascular_trial_110509-2/</loc>
		<lastmod>2009-05-11T06:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/axelar_completes_single_day_oral_dosing_part_in_phase_iii_cancer_study_110509-2/</loc>
		<lastmod>2009-05-11T06:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/wyeths_bla_for_prevnar_13_wins_fda_priority_review_110509-2/</loc>
		<lastmod>2009-05-11T06:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/oxygen_biotherapeutics_wins_orphan_designation_for_brain_injury_drug_110509-2/</loc>
		<lastmod>2009-05-11T07:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/avi_biopharma_wins_contract_for_development_of_muscular_dystrophy_drug_110509-2/</loc>
		<lastmod>2009-05-11T08:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tekmira_wins_fda_clearance_to_initiate_phase_i_study_of_cholesterol_drug_110509-2/</loc>
		<lastmod>2009-05-11T09:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amt_initiates_preregistration_clinical_trial_for_glybera_110509-2/</loc>
		<lastmod>2009-05-11T09:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/affymetrix_elects_gary_s_guthart_to_its_board_090511-2/</loc>
		<lastmod>2009-05-11T10:02:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sadra_medical_secures_30m_in_financing_110509-2/</loc>
		<lastmod>2009-05-11T10:09:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/entellus_medical_initiates_enrollment_in_rhinosinusitis_study_110509-2/</loc>
		<lastmod>2009-05-11T10:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/actelion_wins_positive_review_for_phase_iii_pulmonary_fibrosis_study_110509-2/</loc>
		<lastmod>2009-05-11T11:44:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofiaventis_builds_new_manufacturing_facility_in_france_090512-2/</loc>
		<lastmod>2009-05-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/daxor_posts_net_loss_of_15_million_in_q1_2009_090512-2/</loc>
		<lastmod>2009-05-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/seracare_life_sciences_posts_revenues_of_108_million_for_q2_fiscal_2009_090512-2/</loc>
		<lastmod>2009-05-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alpha_innotech_posts_36_million_revenues_in_q1_2009_090512-2/</loc>
		<lastmod>2009-05-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ibt_posts_profit_of_eur967_million_in_q1_2009_090512-2/</loc>
		<lastmod>2009-05-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/osmetech_chosen_as_supplier_for_a_major_clinical_trial_090512-2/</loc>
		<lastmod>2009-05-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/implicit_bioscience_and_cmc_icos_biologics_sign_manufacturing_agreement_120509-2/</loc>
		<lastmod>2009-05-12T05:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pari_pharma_wins_orphan_drug_designation_for_cystic_fibrosis_therapy_120509-2/</loc>
		<lastmod>2009-05-12T05:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novo_nordisk_reports_encouraging_results_from_diabetes_study_120509-2/</loc>
		<lastmod>2009-05-12T06:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novavax_q1_net_loss_increases_to_835m_120509-2/</loc>
		<lastmod>2009-05-12T06:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/helix_biomed_q1_net_loss_narrows_to_919743_120509-2/</loc>
		<lastmod>2009-05-12T06:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gilead_reports_encouraging_results_from_phase_iii_hypertension_trial_120509-2/</loc>
		<lastmod>2009-05-12T07:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nycomed_files_european_maa_for_lung_drug_120509-2/</loc>
		<lastmod>2009-05-12T08:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eos_secures_45m_committed_equity_financing_facility_120509-2/</loc>
		<lastmod>2009-05-12T09:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck_serono_initiates_phase_iii_parkinsons_disease_study_120509-2/</loc>
		<lastmod>2009-05-12T09:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/takeda_to_launch_sales_and_marketing_operation_in_portugal_120509-2/</loc>
		<lastmod>2009-05-12T10:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/minnesota_first_to_ban_bpa_120509-2/</loc>
		<lastmod>2009-05-12T11:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/socma_acquires_chemallianceorg_from_epa_120509-2/</loc>
		<lastmod>2009-05-12T12:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abmc_posts_net_sales_of_22_million_for_q1_2009_090513-2/</loc>
		<lastmod>2009-05-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/transgenomic_posts_net_sales_of_5_million_for_q1_2009_090513-2/</loc>
		<lastmod>2009-05-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/concert_pharmaceuticals_wins_new_patents_on_deuterium_modified_compounds_130509-2/</loc>
		<lastmod>2009-05-13T11:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ipsogen_introduces_new_breast_cancer_genomic_test_130509-2/</loc>
		<lastmod>2009-05-13T12:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/inhibitex_initiates_phase_ii_shingles_trial_130509-2/</loc>
		<lastmod>2009-05-13T12:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/methylgene_q1_net_loss_widens_to_c61m_130509-2/</loc>
		<lastmod>2009-05-13T13:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/takeda_to_integrate_its_ireland_subsidiaries_130509-2/</loc>
		<lastmod>2009-05-13T13:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lipoxen_path_join_hands_for_malaria_vaccine_090513-2/</loc>
		<lastmod>2009-05-13T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/halozyme_q1_net_loss_widens_to_1472m_130509-2/</loc>
		<lastmod>2009-05-13T13:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/daiichi_sankyo_reports_blood_pressure_reduction_data_from_roadmap_study_130509-2/</loc>
		<lastmod>2009-05-13T15:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/archimedes_pharma_reports_positive_results_from_phase_iii_cancer_pain_trial_130509-2/</loc>
		<lastmod>2009-05-13T16:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/corgenix_posts_net_sales_of_2_million_for_q3_fiscal_2009_090514-2/</loc>
		<lastmod>2009-05-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/china_sky_posts_net_income_of_72_million_in_q1_2009_090514-2/</loc>
		<lastmod>2009-05-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medapps_forms_partnership_with_microsoft_140509-2/</loc>
		<lastmod>2009-05-14T01:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/glaxosmithkline_extends_collaboration_with_aspen_140509-2/</loc>
		<lastmod>2009-05-14T05:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/acucela_reports_new_encouraging_data_from_dry_amd_study_140509-2/</loc>
		<lastmod>2009-05-14T07:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cardiola_wins_ce_mark_recertification_for_mpulse_system_140509-2/</loc>
		<lastmod>2009-05-14T08:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk_wins_fda_approval_for_dissolvable_version_of_epilepsy_drug_140509-2/</loc>
		<lastmod>2009-05-14T08:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/st_jude_medical_wins_ce_mark_for_ensite_velocity_cardiac_mapping_system_140509-2/</loc>
		<lastmod>2009-05-14T08:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/targacept_reports_positive_top_line_results_from_phase_ii_adhd_trial_140509-2/</loc>
		<lastmod>2009-05-14T10:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dara_biosciences_reports_positive_results_from_phase_iia_pain_trial_140509-2/</loc>
		<lastmod>2009-05-14T10:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/quest_diagnostics_launches_new_swine_flu_test_140509-2/</loc>
		<lastmod>2009-05-14T10:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nerviano_medical_wins_fda_approval_to_initiate_phase_i_cancer_trial_140509-2/</loc>
		<lastmod>2009-05-14T11:24:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/osmetech_submits_swine_flu_test_to_fda_140509-2/</loc>
		<lastmod>2009-05-14T11:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ym_biosciences_posts_net_loss_of_cad35_million_in_q1_2009_090514-2/</loc>
		<lastmod>2009-05-14T12:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ucbs_rheumatoid_arthritis_drug_gets_fda_approval_090514-2/</loc>
		<lastmod>2009-05-14T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amdl_posts_net_revenues_of_27_million_for_q1_2009_090515-2/</loc>
		<lastmod>2009-05-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/schering_plough_initiates_enrollment_in_phase_iii_study_of_heart_drug_150509-2/</loc>
		<lastmod>2009-05-15T07:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novimmune_raises_548m_in_equity_financing_150509-2/</loc>
		<lastmod>2009-05-15T08:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nhlbi_stops_enrollment_in_traumatic_brain_injury_study_150509-2/</loc>
		<lastmod>2009-05-15T09:54:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/oncolytics_biotech_completes_enrollment_in_phase_ii_sarcoma_trial_150509-2/</loc>
		<lastmod>2009-05-15T10:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/axiomed_spine_wins_ce_mark_for_freedom_lumbar_disc-2/</loc>
		<lastmod>2009-05-15T10:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ucb_wins_fda_approval_for_arthritis_drug_150509-2/</loc>
		<lastmod>2009-05-15T10:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/competitive_technologies_wins_new_patent_for_nanoparticle_bone_biomaterial_150509-2/</loc>
		<lastmod>2009-05-15T11:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/rafael_medical_wins_fda_clearance_for_safeflo_vena_cava_filter_150509-2/</loc>
		<lastmod>2009-05-15T11:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/viracor_laboratories_launches_new_cytomegalovirus_test_150509-2/</loc>
		<lastmod>2009-05-15T11:39:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lipoxen_obtains_funding_for_malaria_vaccine_project_150509-2/</loc>
		<lastmod>2009-05-15T11:55:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/addrenex_licenses_new_narcolepsy_drug_150509-2/</loc>
		<lastmod>2009-05-15T12:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alkermes_initiates_two_new_trials_of_oral_opioid_modulator_150509-2/</loc>
		<lastmod>2009-05-15T13:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/new_cure_for_skin_cancer_090515-2/</loc>
		<lastmod>2009-05-15T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbott_receives_premarket_fda_approval_for_architect_core_090516-2/</loc>
		<lastmod>2009-05-15T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dysport_to_give_jitters_to_botox_090517-2/</loc>
		<lastmod>2009-05-17T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/glaxo_to_make_swineflu_vaccine_090517-2/</loc>
		<lastmod>2009-05-17T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/onyx_files_complaint_against_bayer_090517-2/</loc>
		<lastmod>2009-05-17T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/baxter_plans_to_invest_1465_million_in_china_090518-2/</loc>
		<lastmod>2009-05-17T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/drug_rd_projects_get_e246m_under_imi_scheme_090518-2/</loc>
		<lastmod>2009-05-18T10:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/clinical_study_reveals_lightactivated_drug_therapy_to_treat_cancer_090518-2/</loc>
		<lastmod>2009-05-18T10:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/indian_crams_players_scrambling_for_eu_market_090518-2/</loc>
		<lastmod>2009-05-18T10:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck_serono_to_invest_in_innovation_in_fertility_area_090518-2/</loc>
		<lastmod>2009-05-18T10:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/us_states_join_medicaids_lawsuits_against_wyeth_090518-2/</loc>
		<lastmod>2009-05-18T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/japanese_firm_acquires_californiabased_victory_pharma_090518-2/</loc>
		<lastmod>2009-05-18T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/osmetech_molecular_signs_service_agreement_with_trilink_090518-2/</loc>
		<lastmod>2009-05-18T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genprobe_appoints_carl_hull_as_ceo_090518-2/</loc>
		<lastmod>2009-05-18T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/wellcare_resolves_sec_probe_090518-2/</loc>
		<lastmod>2009-05-18T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/algeria_to_prohibit_800_imported_drugs_by_2012_090518-2/</loc>
		<lastmod>2009-05-18T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biovail_to_acquire_worldwide_drug_rights_090518-2/</loc>
		<lastmod>2009-05-18T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/quigley_may_sell_its_pharma_division_090518-2/</loc>
		<lastmod>2009-05-18T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/piramal_launches_trial_material_packaging_capacity_in_uk_090519-2/</loc>
		<lastmod>2009-05-19T10:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/elixir_signs_option_agreement_with_novartis_090519-2/</loc>
		<lastmod>2009-05-19T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/enobias_enzyme_replacement_therapy_gets_fda_fasttrack_status_090519-2/</loc>
		<lastmod>2009-05-19T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/glaxo_provides_50m_pandemic_vaccines_090519-2/</loc>
		<lastmod>2009-05-19T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/renovo_splits_juvidex_into_two_090519-2/</loc>
		<lastmod>2009-05-19T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sucampo_starts_phase_iii_trial_of_lubiprostone_for_idiopathic_constipation_090519-2/</loc>
		<lastmod>2009-05-19T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lilly_medtronic_form_strategic_marketing_alliance_090519-2/</loc>
		<lastmod>2009-05-19T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cardiomes_agreement_with_merck_and_its_affiliate_now_effective_090519-2/</loc>
		<lastmod>2009-05-19T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biogen_and_genentech_seek_fda_nod_for_rituxan_090519-2/</loc>
		<lastmod>2009-05-19T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/drug_makers_seek_change_of_product_lines_without_new_licence_090519-2/</loc>
		<lastmod>2009-05-19T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck_to_release_tredaptive_in_mexico_germany_uk_090519-2/</loc>
		<lastmod>2009-05-19T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/branded_drugs_face_generic_challenge_in_japan_090519-2/</loc>
		<lastmod>2009-05-19T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/solvay_licenses_drug_rights_from_lipocine_090519-2/</loc>
		<lastmod>2009-05-19T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/escalon_posts_92_million_net_revenues_for_q3_fiscal_2009_090519-2/</loc>
		<lastmod>2009-05-19T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nexavar_gets_approval_in_japan_for_liver_cancer_090520-2/</loc>
		<lastmod>2009-05-20T10:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gw_files_sativex_for_spasticity_treatment_090520-2/</loc>
		<lastmod>2009-05-20T13:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cholesterol_drug_mipomersen_trial_attains_objective_090520-2/</loc>
		<lastmod>2009-05-20T13:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cancer_research_uk_gsk_to_jointly_develop_anticancer_drug_090520-2/</loc>
		<lastmod>2009-05-20T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/moksha8_roche_expands_alliance_for_brazilian_and_mexican_markets_090520-2/</loc>
		<lastmod>2009-05-20T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer_inks_marketing_pact_with_claris_090520-2/</loc>
		<lastmod>2009-05-20T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/advaxis_to_develop_oral_formulation_of_live_listeria_090520-2/</loc>
		<lastmod>2009-05-20T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mediware_to_takeover_scihealth_090520-2/</loc>
		<lastmod>2009-05-20T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/xyntha_sales_exceed_bdi_pharmas_q1_projections_090520-2/</loc>
		<lastmod>2009-05-20T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sagent_pharmaceuticals_raises_30m_for_product_launches_090520-2/</loc>
		<lastmod>2009-05-20T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/epa_deadline_for_area_sources_rule_extended_210509-2/</loc>
		<lastmod>2009-05-21T10:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dow_to_raise_900m_from_divestment_210509-2/</loc>
		<lastmod>2009-05-21T11:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cleveland_biolabs_to_form_joint_venture_in_russia_090521-2/</loc>
		<lastmod>2009-05-21T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eli_lilly_launches_two_global_trials_for_alzheimers_disease_090521-2/</loc>
		<lastmod>2009-05-21T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/johnson__johnson_acquires_cougar_for_1b_090521-2/</loc>
		<lastmod>2009-05-21T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/neurogesx_gets_european_commission_nod_for_qutenza_090521-2/</loc>
		<lastmod>2009-05-21T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/human_genome_sciences_seeks_fda_approval_for_anthrax_drug_090521-2/</loc>
		<lastmod>2009-05-21T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/qlt_announces_court_response_to_motion_to_dismiss_and_removal_of_case_to_federal_court_090521-2/</loc>
		<lastmod>2009-05-21T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nusil_acquires_antifoam_business_from_bluestar_silicones_090521-2/</loc>
		<lastmod>2009-05-21T14:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cancer_therapeutics_plans_to_acquire_25_stake_in_nanotherapies_090522-2/</loc>
		<lastmod>2009-05-22T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/conceptus_files_lawsuit_against_hologic_090522-2/</loc>
		<lastmod>2009-05-22T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dr_reddys_restructures_organisation_gets_approval_for_three_inds_090522-2/</loc>
		<lastmod>2009-05-22T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/us_to_grant_800m_to_pharma_majors_for_swine_flu_vaccine_090523-2/</loc>
		<lastmod>2009-05-23T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/us_department_of_agriculture_grants_approval_for_bayers_glytol_cotton_technology_090524-2/</loc>
		<lastmod>2009-05-24T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/shionogi_plans_to_market_new_flu_drug_in_japan_090524-2/</loc>
		<lastmod>2009-05-24T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/new_policies_evolving_as_retractable_safety_syringe_suppliers_strive_for_traction_090525-2/</loc>
		<lastmod>2009-05-25T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/att_other_firms_test_devices_to_track_patient_progress_090525-2/</loc>
		<lastmod>2009-05-25T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/zcube_yissum_research_ink_licensing_deal_090525-2/</loc>
		<lastmod>2009-05-25T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/csl_in_talks_with_ftc_to_acquire_talecris_090525-2/</loc>
		<lastmod>2009-05-25T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/us_hhs_purchases_gsks_swine_flu_vaccine_and_adjuvant_system_090525-2/</loc>
		<lastmod>2009-05-25T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ekomeds_tb_drug_immunoxel_gets_approval_in_south_africa_090525-2/</loc>
		<lastmod>2009-05-25T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/acadia_pharmaceuticals_and_meiji_seika_kaisha_collaborates_for_schizophrenia_drug_090525-2/</loc>
		<lastmod>2009-05-25T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/antipodean_pharmaceuticals_initiates_phase_ii_trial_for_parkinsons_disease_090525-2/</loc>
		<lastmod>2009-05-25T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi_receives_190m_for_new_influenza_ah1n1_virus_vaccine_090525-2/</loc>
		<lastmod>2009-05-25T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alcon_launches_first_pharmaceutical_manufacturing_plant_in_asia_090525-2/</loc>
		<lastmod>2009-05-25T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roches_phase_iii_actemra_study_achieves_goal_090525-2/</loc>
		<lastmod>2009-05-25T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eisai_gsk_collaborates_for_paritec_in_india_090526-2/</loc>
		<lastmod>2009-05-26T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/oci_gets_brazilian_fda_approval_for_monitors_sensors_090526-2/</loc>
		<lastmod>2009-05-26T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gene_bridges_licenses_recombineering_technology_to_chugai_pharmaceutical_090526-2/</loc>
		<lastmod>2009-05-26T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/spectrum_pharmaceuticals_wins_arbitration_with_cell_therapeutics_090526-2/</loc>
		<lastmod>2009-05-26T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/applied_biosystems_unveils_3500_series_and_3500_dx_series_genetic_analyzers_090526-2/</loc>
		<lastmod>2009-05-26T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cerus_grifols_extends_intercept_blood_system_distribution_to_italy_090526-2/</loc>
		<lastmod>2009-05-26T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/philips_unveils_three_new_products_to_improve_performance_and_patient_comfort_for_hospital_and_home_ventilation_090526-2/</loc>
		<lastmod>2009-05-26T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/map_pharmaceuticals_phase_iii_trial_of_migraine_drug_meets_all_primary_endpoints_090526-2/</loc>
		<lastmod>2009-05-26T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medinox_logical_therapeutics_declares_clinical_results_for_naproxen_prodrug_090526-2/</loc>
		<lastmod>2009-05-26T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/advamed_spends_036_million_lobbying_in_q1_2009_090526-2/</loc>
		<lastmod>2009-05-26T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/elekta_to_provide_software_solutions_to_procure_090526-2/</loc>
		<lastmod>2009-05-26T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amgen_acquires_right_to_cytokinetics_heart_drug_090526-2/</loc>
		<lastmod>2009-05-26T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fisher__paykel_fiscal_2009_operating_revenue_up_28_090526-2/</loc>
		<lastmod>2009-05-26T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astella_to_launch_protopic_ointment_in_europe_090526-2/</loc>
		<lastmod>2009-05-26T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_extends_review_timeline_for_stelara_090526-2/</loc>
		<lastmod>2009-05-26T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/united_therapeutics_gets_fda_approval_for_adcirca_090526-2/</loc>
		<lastmod>2009-05-26T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/simcere_acquires_375_stake_in_jiangsu_yanshen_090526-2/</loc>
		<lastmod>2009-05-26T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/new_antiepileptic_drug_to_be_available_in_us_090526-2/</loc>
		<lastmod>2009-05-26T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eu_grants_marketing_authorization_to_hra_pharmas_ellaone_090526-2/</loc>
		<lastmod>2009-05-26T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kinemed_enters_into_collaboration_with_bristolmyers_squibb_090526-2/</loc>
		<lastmod>2009-05-26T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/china_sky_one_medical_gets_approval_for_two_new_drugs_090526-2/</loc>
		<lastmod>2009-05-26T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/phase_i_trial_on_compound_developed_from_amri_bristolmyers_squibb_collaboration_090526-2/</loc>
		<lastmod>2009-05-26T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/house_bill_would_allow_patients_to_sue_over_faulty_medical_devices_090526-2/</loc>
		<lastmod>2009-05-26T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hanger_orthopedic_acquires_two_firms_090526-2/</loc>
		<lastmod>2009-05-26T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medarex_gets_approval_for_mdx1338_090527-2/</loc>
		<lastmod>2009-05-27T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/verus_pharmaceuticals_files_lawsuit_against_astrazeneca_and_tika_090527-2/</loc>
		<lastmod>2009-05-27T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sectra_to_provide_radiology_information_system_to_shields_health_090527-2/</loc>
		<lastmod>2009-05-27T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi_pasteur_receives_seed_virus_to_produce_new_influenza_vaccine_090527-2/</loc>
		<lastmod>2009-05-27T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/access_pharmaceuticals_launches_mugard_090527-2/</loc>
		<lastmod>2009-05-27T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fdas_proposed_advertising_guidelines_could_impact_some_highrisk_genetic_tests_090527-2/</loc>
		<lastmod>2009-05-27T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medivation_selects_protrials_to_conduct_global_phase_iii_trials_090527-2/</loc>
		<lastmod>2009-05-27T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sciele_pharma_acquires_global_rights_for_psd502_from_plethora_solutions_090527-2/</loc>
		<lastmod>2009-05-27T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/world_of_medicine_raises_investments_in_research__development_sales_expansion_090527-2/</loc>
		<lastmod>2009-05-27T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/boston_scientific_gets_approval_for_taxus_liberte_atom_stent_system_090527-2/</loc>
		<lastmod>2009-05-27T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biostar_witnesses_continued_growth_in_revenues_090527-2/</loc>
		<lastmod>2009-05-27T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/accumetrics_announces_european_distribution_channels_090527-2/</loc>
		<lastmod>2009-05-27T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medical_technology_prices_slow_to_increase_small_portion_of_nhe_advamed_study_finds_090527-2/</loc>
		<lastmod>2009-05-27T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tb_alliance_signs_four_drug_discovery_collaboration_agreements_090527-2/</loc>
		<lastmod>2009-05-27T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/avita_medical_gets_145_million_funding_from_afirm_090527-2/</loc>
		<lastmod>2009-05-27T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi_pharma_bristolmyers_squibb_withdraws_marketing_authorisation_application_090527-2/</loc>
		<lastmod>2009-05-27T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/clinipace_to_manage_two_clinical_trials_for_inspire_090527-2/</loc>
		<lastmod>2009-05-27T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vertex_begins_phase_iii_registration_program_for_cystic_fibrosis_090527-2/</loc>
		<lastmod>2009-05-27T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/intercells_phase_ii_trial_of_ve_patch_begins_090528-2/</loc>
		<lastmod>2009-05-28T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aventis_pharma_to_pay_955m_to_settle_false_claims_act_allegations_090528-2/</loc>
		<lastmod>2009-05-28T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/emea_validates_gileads_marketing_authorisation_application_for_regadenoson_090528-2/</loc>
		<lastmod>2009-05-28T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biocis_initiates_phase_i_clinical_trial_for_cancer_090528-2/</loc>
		<lastmod>2009-05-28T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amt_receives_orphan_drug_designation_for_porphyria_090528-2/</loc>
		<lastmod>2009-05-28T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bayer_healthcare_to_initiate_phase_iii_trial_for_liver_cancer_drug_090528-2/</loc>
		<lastmod>2009-05-28T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/realtimetechnologies_to_establish_headquarters_in_massachusetts_090528-2/</loc>
		<lastmod>2009-05-28T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/qiagen_to_supply_molecular_screening_solutions_to_increase_safety_of_blood_donations_in_brazil_090528-2/</loc>
		<lastmod>2009-05-28T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi_aventis_exelixis_signs_agreement_for_oncology_therapies_090528-2/</loc>
		<lastmod>2009-05-28T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medicinova_to_modify_phase_ii_asthma_clinical_drug_trial_090528-2/</loc>
		<lastmod>2009-05-28T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fcc_may_widen_spectrum_for_wireless_radio_devices_090528-2/</loc>
		<lastmod>2009-05-28T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astellas_receives_fda_approval_for_prograf_090528-2/</loc>
		<lastmod>2009-05-28T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uk_merges_four_nhs_centers_into_new_guideline_group_090528-2/</loc>
		<lastmod>2009-05-28T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis_increases_offer_price_for_novartis_india_090528-2/</loc>
		<lastmod>2009-05-28T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sciele_plethoras_phase_iii_trial_on_psd502_yields_desired_results_090528-2/</loc>
		<lastmod>2009-05-28T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer_wins_recommendation_for_sutent_090528-2/</loc>
		<lastmod>2009-05-28T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/perot_systems_signs_contract_with_amerinet_090528-2/</loc>
		<lastmod>2009-05-28T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/caraco_reports_20_decline_in_gross_profit_for_fiscal_2009_090528-2/</loc>
		<lastmod>2009-05-28T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/covidien_approves_change_in_place_of_incorporation_from_bermuda_to_ireland_090528-2/</loc>
		<lastmod>2009-05-28T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/qiagen_awards_development_contract_to_plexus_090528-2/</loc>
		<lastmod>2009-05-28T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bayer_receives_fdas_complete_response_letter_for_rivaroxaban_090528-2/</loc>
		<lastmod>2009-05-28T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/meridian_signs_distribution_contract_with_lipolaser_usa_for_ohio_indiana_and_kentucky_state_090528-2/</loc>
		<lastmod>2009-05-28T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/varian_medical_systems_to_showcase_brachytherapy_cancer_treatment_equipment_and_software_at_american_brachytherapy_society_2009_meeting_090529-2/</loc>
		<lastmod>2009-05-29T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/keryx_renal_cell_cancer_study_shows_positive_results_090529-2/</loc>
		<lastmod>2009-05-29T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biosyent_releases_q109_results_sales_down_090529-2/</loc>
		<lastmod>2009-05-29T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mylan_gets_tentative_fda_approval_for_singulair_090529-2/</loc>
		<lastmod>2009-05-29T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazenecas_regulatory_update_for_seroquel_xr_090529-2/</loc>
		<lastmod>2009-05-29T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dey_to_market_emsam_skin_patch_in_us_090529-2/</loc>
		<lastmod>2009-05-29T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/positive_outcome_for_catalyst_pharmaceuticals_phase_ii_clinical_trial_on_cpp109_090529-2/</loc>
		<lastmod>2009-05-29T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chmp_recommends_novartis_eu_approved_afinitor_for_patients_with_advanced_kidney_cancer_090529-2/</loc>
		<lastmod>2009-05-29T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/summit_biomarin_restructures_muscular_dystrophy_agreement_090529-2/</loc>
		<lastmod>2009-05-29T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bsd_medical_names_timothy_mcquay_as_its_chairman_090529-2/</loc>
		<lastmod>2009-05-29T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/glaxosmithkline_genmab_wins_fda_recommendation_for_arzerra_090529-3/</loc>
		<lastmod>2009-05-29T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/boehringer_ingelheim_dxs_sign_collaboration_agreement_090529-3/</loc>
		<lastmod>2009-05-29T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eli_lilly_receives_positive_opinion_for_alimta_090529-2/</loc>
		<lastmod>2009-05-29T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer_reveals_results_for_four_lung_cancer_trials_090530-2/</loc>
		<lastmod>2009-05-30T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roches_phase_iii_atlas_study_achieves_expected_success_090530-2/</loc>
		<lastmod>2009-05-30T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer_upbeat_about_study_results_for_nsclc_treatment_090530-2/</loc>
		<lastmod>2009-05-30T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/oncogenex_trial_results_for_ogx011_satisfactory_090530-2/</loc>
		<lastmod>2009-05-30T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer_celldex_provides_update_on_brain_cancer_studies_090530-2/</loc>
		<lastmod>2009-05-30T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/elan_biogen_idec_study_reveals_positive_results_for_tysabri_090531-2/</loc>
		<lastmod>2009-05-31T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi_aventis_bsi201_showed_clinical_benefit_in_tnbc_patients_090531-2/</loc>
		<lastmod>2009-05-31T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/immunomedics_pancreatic_cancer_trial_results_positive_090531-2/</loc>
		<lastmod>2009-05-31T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ironwood_forests_additional_analysis_reveals_expected_outcome_090531-2/</loc>
		<lastmod>2009-05-31T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lillys_gemzar_successful_in_improving_progressionfree_survival_in_cervical_cancer_patients_090531-2/</loc>
		<lastmod>2009-05-31T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medtronic_announces_appeal_decision_in_patent_litigation_with_depuy_spine_090601-2/</loc>
		<lastmod>2009-06-01T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ym_biosciences_nimotuzumab_demonstrates_efficacy_in_randomized_head__neck_cancer_090601-2/</loc>
		<lastmod>2009-06-01T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/innovative_spinal_files_for_chapter_7_bankruptcy_090601-2/</loc>
		<lastmod>2009-06-01T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medimmune_bags_contract_from_hhs_to_manufacture_laiv_for_novel_influenza_a_h1n1_090601-2/</loc>
		<lastmod>2009-06-01T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/health_industry_organizations_send_detailed_proposal_on_health_care_reform_to_president_obama_090601-2/</loc>
		<lastmod>2009-06-01T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca_merck_collaborate_to_investigate_novel_combination_anticancer_regimen_090601-2/</loc>
		<lastmod>2009-06-01T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nxstage_expands_supply_agreement_with_b_braun_to_include_streamline_technology_090601-2/</loc>
		<lastmod>2009-06-01T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cephalon_makes_available_nuvigil_for_treatment_of_excessive_sleepiness_090601-2/</loc>
		<lastmod>2009-06-01T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bayer_onyx_initiates_phaseiii_trial_of_nexavar_in_nsclc_090601-2/</loc>
		<lastmod>2009-06-01T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ge_healthcare_enters_into_joint_research_program_with_qstp_090601-2/</loc>
		<lastmod>2009-06-01T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/enzon_hif1_alpha_antagonist_study_shows_signs_of_clinical_benefit_090601-2/</loc>
		<lastmod>2009-06-01T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kendle_expands_asiapacific_operations_090601-3/</loc>
		<lastmod>2009-06-01T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/rigel_r788_evaluated_in_phase_ii_trial_in_multiple_cancers_090601-3/</loc>
		<lastmod>2009-06-01T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis_pharma_nordic_bioscience_phase_iii_study_for_knee_osteoarthritis_treatment_090601-3/</loc>
		<lastmod>2009-06-01T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_refuses_arca_nda_on_gencaro_seeks_additional_trial_090601-2/</loc>
		<lastmod>2009-06-01T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ohrp_clarifies_significance_of_its_irb_registration_090601-2/</loc>
		<lastmod>2009-06-01T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cerus_grifols_collaborate_for_red_blood_cell_treatment_090602-2/</loc>
		<lastmod>2009-06-02T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/edap_signs_distribution_agreements_in_argentina_brazil_and_chile_090602-2/</loc>
		<lastmod>2009-06-02T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/polymedix_bags_dtra_contract_to_develop_antibiotic_compounds_against_biowarfare_pathogens_090602-2/</loc>
		<lastmod>2009-06-02T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer_discontinues_sunitinib_plus_paclitaxel_trial_090602-2/</loc>
		<lastmod>2009-06-02T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer_launches_new_treatment_for_overactive_bladder_090602-2/</loc>
		<lastmod>2009-06-02T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/arbor_launches_zinotic_es_in_us_090602-2/</loc>
		<lastmod>2009-06-02T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bayer_genzyme_finalize_strategic_alliance_090602-2/</loc>
		<lastmod>2009-06-02T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/delcath_wins_third_orphan_drug_designation_090602-2/</loc>
		<lastmod>2009-06-02T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medivation_phase_12_trial_of_mdv3100_for_prostate_cancer_patients_yield_positive_results_090602-2/</loc>
		<lastmod>2009-06-02T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/siemens_healthcare_showcases_new_imaging_it_innovations_at_siim_2009_090602-2/</loc>
		<lastmod>2009-06-02T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sfda_approves_diclofenac_sodium_eye_drops_090602-2/</loc>
		<lastmod>2009-06-02T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/luminex_establishes_new_facility_in_shanghai_china_090602-2/</loc>
		<lastmod>2009-06-02T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uk_outlines_vigilance_system_for_cemarked_coronary_stents_090602-2/</loc>
		<lastmod>2009-06-02T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/unfavorable_fda_review_for_advanced_life_sciences_restanza_090602-2/</loc>
		<lastmod>2009-06-02T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nanogen_plans_to_lay_off_89_employees_090602-2/</loc>
		<lastmod>2009-06-02T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/royal_philips_signs_agreement_with_sant_pau_hospital_to_manage_imaging_technology_090602-2/</loc>
		<lastmod>2009-06-02T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/stiefel_completes_phaseiii_clinical_trial_for_hyphanox_090602-2/</loc>
		<lastmod>2009-06-02T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cordex_obtains_fda_special_protocol_assessment_approval_for_atpace_090602-2/</loc>
		<lastmod>2009-06-02T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/concert_pharmaceuticals_glaxosmithkline_collaborate_for_deuteriumcontaining_medicines_090602-2/</loc>
		<lastmod>2009-06-02T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_approves_glaxosmithkline_lamictal_xr_for_epilepsy_treatment_090602-2/</loc>
		<lastmod>2009-06-02T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pari_pharma_clinical_trial_results_for_liposomal_cyclosporinea_successful_090602-2/</loc>
		<lastmod>2009-06-02T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/schering_plough_wins_marketing_approval_for_sycrest_090602-2/</loc>
		<lastmod>2009-06-02T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/neurogesx_gets_fda_orphan_drug_designation_for_qutenza_for_treatment_of_phn_090602-2/</loc>
		<lastmod>2009-06-02T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amerisourcebergen_purchases_innomar_strategies_090602-2/</loc>
		<lastmod>2009-06-02T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/arbor_unveils_zinotic_es_090602-2/</loc>
		<lastmod>2009-06-02T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novo_nordisk_to_initiate_comparative_study_for_levemir_090602-2/</loc>
		<lastmod>2009-06-02T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cegedim_dendrite_to_provide_mobile_intelligence_crm_to_sanofi_aventis_090603-2/</loc>
		<lastmod>2009-06-03T08:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/johnson__johnson_reports_data_on_tmc207_for_treatment_of_mdr_tuberculosis_090603-2/</loc>
		<lastmod>2009-06-03T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/combinatorx_declares_positive_results_for_ar_synavive_090603-2/</loc>
		<lastmod>2009-06-03T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lcavision_promotes_david_thomas_as_coo_090603-2/</loc>
		<lastmod>2009-06-03T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/peregrine_highlights_data_from_its_three_phaseii_bavituximab_cancer_trials_090603-2/</loc>
		<lastmod>2009-06-03T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/advaxis_gets_fda_response_for_odd_090603-2/</loc>
		<lastmod>2009-06-03T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eyegate_egp437_improves_symptoms_of_dry_eye_syndrome_090603-2/</loc>
		<lastmod>2009-06-03T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pdi_medical_affairs_form_strategic_alliance_090603-2/</loc>
		<lastmod>2009-06-03T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eli_lilly_resubmits_cymbalta_supplemental_new_drug_application_to_fda_090603-2/</loc>
		<lastmod>2009-06-03T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gentas_genasense_achieves_high_response_rates_in_patients_with_advanced_melanoma_090603-2/</loc>
		<lastmod>2009-06-03T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gattex_enhances_intestinal_mass_and_function_of_patients_with_short_bowel_syndrome_090603-2/</loc>
		<lastmod>2009-06-03T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nabi_receives_scientific_advice_on_nicvax_from_emea_090603-2/</loc>
		<lastmod>2009-06-03T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cyberonics_posts_net_income_of_267_million_in_fiscal_2009_090603-2/</loc>
		<lastmod>2009-06-03T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/arab_gulf_states_to_spend_60_billion_in_health_care_sector_by_2025_ft__reports_090603-2/</loc>
		<lastmod>2009-06-03T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/coloplast_opens_new_headquarters_in_minneapolis_minnesota_090603-2/</loc>
		<lastmod>2009-06-03T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vical_receives_us_patent_for_universal_influenza_vaccine_approach_090603-2/</loc>
		<lastmod>2009-06-03T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/combimatrix_issues_herscan_clinical_study_results_090603-2/</loc>
		<lastmod>2009-06-03T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/optos_cfo_allan_watson_plans_to_step_down_090603-2/</loc>
		<lastmod>2009-06-03T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pericor_therapeutics_gp531_preclinical_results_positive_090603-2/</loc>
		<lastmod>2009-06-03T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis_ilaris_offers_long_term_remission_for_caps_090603-2/</loc>
		<lastmod>2009-06-03T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dmc_reviews_affymax_hematide_090603-2/</loc>
		<lastmod>2009-06-03T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/agilent_wins_patent_dispute_with_affymetrix_for_microarray_hybridization_090604-2/</loc>
		<lastmod>2009-06-03T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/synthetech_announces_fiscal_2009_results_040609-2/</loc>
		<lastmod>2009-06-04T11:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/neuralstem_receives_patent_for_neuron_growth_compounds_090604-2/</loc>
		<lastmod>2009-06-04T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/wyeth_enbrel_gets_positive_european_recommendations_090604-2/</loc>
		<lastmod>2009-06-04T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/viropharma_gets_complete_response_letter_from_fda_090604-2/</loc>
		<lastmod>2009-06-04T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lpath_gets_3m_grant_from_nci_090604-2/</loc>
		<lastmod>2009-06-04T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/asymchem_receives_drug_manufacturing_certification_from_sfda_090604-2/</loc>
		<lastmod>2009-06-04T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/xtent_receives_conditional_fda_approval_for_ide_of_custom_nx_drug_eluting_stent_system_090604-2/</loc>
		<lastmod>2009-06-04T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nih_agrees_to_evaluate_novavax_drug_for_h1n1_strain_090604-2/</loc>
		<lastmod>2009-06-04T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lnabased_hif1_alpha_inhibitor_shows_early_signs_of_clinical_benefit_090604-2/</loc>
		<lastmod>2009-06-04T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medical_equipments_industry_needs_to_focus_on_partnerships_and_rd_niper_study_090604-2/</loc>
		<lastmod>2009-06-04T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/epicept_new_data_demonstrates_long_term_durability_of_ceplene_090604-2/</loc>
		<lastmod>2009-06-04T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbott_astrazeneca_signs_agreement_to_copromote_trilipix_090604-2/</loc>
		<lastmod>2009-06-04T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis_wellcome_trust_to_develop_vaccine_for_typhoid_fever_090604-2/</loc>
		<lastmod>2009-06-04T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/anadys_strategic_restructuring_to_focus_on_hepatitis_c_drug_090604-2/</loc>
		<lastmod>2009-06-04T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/avi_biopharma_signs_additional_drug_development_contract_with_charleys_fund_090604-2/</loc>
		<lastmod>2009-06-04T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/access_to_publish_data_from_thiarabine_combination_trial_090604-2/</loc>
		<lastmod>2009-06-04T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbott_astrazeneca_submit_nda_for_certriad_090604-2/</loc>
		<lastmod>2009-06-04T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/haemonetics_receives_favorable_ruling_in_patent_lawsuit_against_competitive_technology_090604-2/</loc>
		<lastmod>2009-06-04T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis_tasigna_positive_in_treating_chronic_myeloid_leukemia_090605-2/</loc>
		<lastmod>2009-06-05T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/proximagen_raises_50m_through_placing_to_acquire_develop_drug_programs_090605-2/</loc>
		<lastmod>2009-06-05T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/who_grants_global_prequalification_to_gsks_rotarix_vaccine_090605-2/</loc>
		<lastmod>2009-06-05T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/magellan_health_services_to_acquire_first_health_services_corporation_090605-2/</loc>
		<lastmod>2009-06-05T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck_rolofylline_fails_efficacy_trial_for_acute_heart_failure_090605-2/</loc>
		<lastmod>2009-06-05T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/somaxon_resubmits_nda_for_silenor_050609-2/</loc>
		<lastmod>2009-06-05T17:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/strativas_nda_for_odfs_accepted_by_fda_110609-2/</loc>
		<lastmod>2009-06-05T17:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vivus_qnexa_results_positive_for_obese_nondiabetic_patients_090606-2/</loc>
		<lastmod>2009-06-06T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mealtime_symlin_to_improve_glucose_control_treatment_satisfaction_090606-2/</loc>
		<lastmod>2009-06-06T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lilly_phaseii_trial_results_for_ly2189265_positive_090606-2/</loc>
		<lastmod>2009-06-06T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/afresa_to_control_post_meal_sugar_levels_in_diabetic_patients_090606-2/</loc>
		<lastmod>2009-06-06T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofiaventis_lantus_witnesses_positive_results_090606-2/</loc>
		<lastmod>2009-06-06T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/xoma_052_results_encouraging_090606-2/</loc>
		<lastmod>2009-06-06T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsks_syncria_improves_glucose_control_reduces_weight_090607-2/</loc>
		<lastmod>2009-06-07T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novo_nordisks_liraglutide_reduces_blood_sugar_weight_090607-2/</loc>
		<lastmod>2009-06-07T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nplate_reduces_splenectomy_rate_treatment_failure_in_patients_with_chronic_itp_090607-2/</loc>
		<lastmod>2009-06-07T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/exenatide_shows_sustained_improvements_in_glycemic_control_with_weight_loss_090607-2/</loc>
		<lastmod>2009-06-07T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/staywell_custom_communications_forms_strategic_alliance_with_siteimprove_080609-2/</loc>
		<lastmod>2009-06-08T10:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/diagnocure_posts_net_loss_of_cad26_million_for_q2_fiscal_2009_090608-2/</loc>
		<lastmod>2009-06-08T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/progenics_ono_pharmaceutical_to_initiate_relistor_clinical_trials_090608-2/</loc>
		<lastmod>2009-06-08T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sangamo_positive_phaseii_results_for_zfp_therapeutic_program_090608-2/</loc>
		<lastmod>2009-06-08T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aeterna_zentaris_acquires_ardana_assets_for_growth_hormone_secretagogue_compound_090608-2/</loc>
		<lastmod>2009-06-08T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofiaventis_to_purchase_diabel_manufacturing_facility_in_frankfurt_090608-2/</loc>
		<lastmod>2009-06-08T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ista_pharmaceuticals_positive_results_for_phaseii_study_of_bromfenac_090608-2/</loc>
		<lastmod>2009-06-08T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/active_biotech_initiates_phaseii_clinical_trial_for_prostate_cancer_drug_090608-2/</loc>
		<lastmod>2009-06-08T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/rexahn_pharmaceuticals_completes_public_equity_offering_090608-2/</loc>
		<lastmod>2009-06-08T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merz_pharmaceuticals_positive_clinical_trials_results_for_nt201_090608-2/</loc>
		<lastmod>2009-06-08T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alnylam_cubist_reports_preliminary_data_from_phase_ii_study_of_alnrsv01_090608-2/</loc>
		<lastmod>2009-06-08T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/expected_results_in_sgn35_trial_in_lymphoma_for_seattle_genetics_090608-2/</loc>
		<lastmod>2009-06-08T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/seattle_genetics_lintuzumab_trial_shows_mixed_results_090608-2/</loc>
		<lastmod>2009-06-08T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/initial_therapy_with_merck_janumet_to_provide_greater_blood_sugar_lowering_090608-2/</loc>
		<lastmod>2009-06-08T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/micromet_blinatumomab_achieves_primary_endpoint_in_phaseii_clinical_trial_090608-2/</loc>
		<lastmod>2009-06-08T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/effective_local_delivery_of_usirna_in_invivo_model_of_bladder_cancer_090608-2/</loc>
		<lastmod>2009-06-08T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/progenics_to_discontinue_hepatitisc_program_090608-2/</loc>
		<lastmod>2009-06-08T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis_afinitor_shows_positive_result_for_patients_with_lymphoma_090608-2/</loc>
		<lastmod>2009-06-08T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/china_biologic_products_signs_private_placement_agreements_to_raise_96m_090608-2/</loc>
		<lastmod>2009-06-08T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sinovac_initiates_influenza_ah1n1_vaccine_production_090608-2/</loc>
		<lastmod>2009-06-08T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sapacitabine_shows_anticancer_activity_in_combination_with_targeted_agents_other_nucleoside_analogs_090608-2/</loc>
		<lastmod>2009-06-08T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/rx_for_africa_forms_strategic_alliance_with_rusan_pharma_090608-2/</loc>
		<lastmod>2009-06-08T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lundbeck_takeda_phaseiii_trial_shows_mixed_results_for_lu_aa21004_090608-2/</loc>
		<lastmod>2009-06-08T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/accumetrics_announces_distribution_channels_in_israel_and_cyprus_090609-2/</loc>
		<lastmod>2009-06-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/millipore_opens_new_bioprocess_manufacturing_facility_in_massachusetts_090609-2/</loc>
		<lastmod>2009-06-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/princeton_physicians_organization_chooses_imedicas_ehr_practice_management_solutions_090609-2/</loc>
		<lastmod>2009-06-09T10:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pdx_rx_works_to_collaborate_with_microsoft_healthvault_090609-2/</loc>
		<lastmod>2009-06-09T10:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d_pharm_receives_fda_approval_for_acute_stroke_drug_090609-2/</loc>
		<lastmod>2009-06-09T12:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roche_selects_fifth_biologic_target_under_collaboration_agreement_with_halozyme_090609-2/</loc>
		<lastmod>2009-06-09T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/arete_shows_positive_clinical_preclinical_results_for_diabetes_drug_090609-2/</loc>
		<lastmod>2009-06-09T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk_shenzhen_neptunus_collaborate_to_develop_manufacture_influenza_vaccines_090609-2/</loc>
		<lastmod>2009-06-09T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbott_launches_eas_myoplex_strength_formula_nutrition_shake_090609-2/</loc>
		<lastmod>2009-06-09T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/positive_results_from_clinical_trial_of_pegpal_for_biomarin_090609-2/</loc>
		<lastmod>2009-06-09T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/penwest_endo_valeant_sign_marketing_agreement_for_opana_er_090609-2/</loc>
		<lastmod>2009-06-09T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_accepts_morphotek_ind_application_for_morab004_090609-2/</loc>
		<lastmod>2009-06-09T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pharmasset_initiates_phase1b_clinical_trial_for_hepatitisc_drug_090609-2/</loc>
		<lastmod>2009-06-09T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biolife_solutions_establishes_new_internal_manufacturing_facility_090609-2/</loc>
		<lastmod>2009-06-09T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/raptor_pharmaceuticals_collaborates_with_roche_on_therapeutic_delivery_across_bloodbrain_barrier_090609-2/</loc>
		<lastmod>2009-06-09T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roche_to_initiate_phaseiii_trials_for_aleglitazar_090609-2/</loc>
		<lastmod>2009-06-09T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eli_lilly_selects_icon_to_manage_its_clinical_trial_site_set_up_and_monitoring_in_europe_090609-2/</loc>
		<lastmod>2009-06-09T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bioniche_synerx_launch_melphalan_hydrochloride_090609-2/</loc>
		<lastmod>2009-06-09T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/celsci_expands_testing_of_its_h1n1_vaccine_using_leaps_technology_090609-2/</loc>
		<lastmod>2009-06-09T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mds_pharma_expands_drug_discovery_capability_in_asia_090609-2/</loc>
		<lastmod>2009-06-09T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dor_receives_protocol_assistance_feedback_from_emea_090609-2/</loc>
		<lastmod>2009-06-09T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tadalafil_tablet_shows_efficacy_safety_for_pulmonary_arterial_hypertension_090609-2/</loc>
		<lastmod>2009-06-09T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/socma_members_advance_industry_priorities_on_capitol_hill_090609-2/</loc>
		<lastmod>2009-06-09T16:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/saltigo_at_the_bos_cmc_forum_june_9_2009_sohuset_conference_center_090609-2/</loc>
		<lastmod>2009-06-09T16:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/umicore_signs_agreement_with_silicycle_090610-2/</loc>
		<lastmod>2009-06-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/topaz_technologies_introduces_biosafety_software_090610-2/</loc>
		<lastmod>2009-06-10T08:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mdrna_gets_fda_approval_for_generic_calcitonin_salmon_nasal_spray_100609-2/</loc>
		<lastmod>2009-06-10T12:47:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vitro_obtains_adult_stem_cell_patent_from_the_us_patent_100609-2/</loc>
		<lastmod>2009-06-10T12:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cannabis_gets_us_federal_government_cagencage_code_certification_100609-2/</loc>
		<lastmod>2009-06-10T13:06:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roche_actemra_to_inhibit_progression_of_structural_joint_damage_in_rheumatoid_arthritis_090610-2/</loc>
		<lastmod>2009-06-10T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_advisory_committee_supports_zyprexa_for_two_adolescent_indications_090610-2/</loc>
		<lastmod>2009-06-10T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/transdel_sings_licensing_agreement_with_jh_direct_090610-2/</loc>
		<lastmod>2009-06-10T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/new_result_shows_high_therapeutic_benefits_for_boehringer_ingelheim_mirapexinsifrol_090610-2/</loc>
		<lastmod>2009-06-10T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/metabasis_merck_to_advance_ampk_activator_for_late_preclinical_development_090610-2/</loc>
		<lastmod>2009-06-10T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roche_provides_updates_on_actemra_for_rheumatoid_arthritis_090610-2/</loc>
		<lastmod>2009-06-10T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mds_nordion_initiates_manufacture_of_cardiac_imaging_agent_090610-2/</loc>
		<lastmod>2009-06-10T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/osteotech_completes_enrollment_for_duratech_bioregeneration_matrix_clinical_trial_090610-2/</loc>
		<lastmod>2009-06-10T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/intekrin_provides_phase_2a_results_for_diabetes_drug_090610-2/</loc>
		<lastmod>2009-06-10T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biobridge_science_jr_scientific_sign_joint_venture_contract_090610-2/</loc>
		<lastmod>2009-06-10T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/altus_inititates_phaseii_trial_of_altu238_090610-2/</loc>
		<lastmod>2009-06-10T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aeterna_zentaris_initiates_extended_study_for_benign_prostatic_hyperplasia_090610-2/</loc>
		<lastmod>2009-06-10T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/response_biomedical_appoints_livleen_kaler_as_vp_finance__administration_and_cfo_090610-2/</loc>
		<lastmod>2009-06-10T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/neurogesx_provides_regulatory_update_for_qutenza_100609-2/</loc>
		<lastmod>2009-06-10T16:49:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/access_pharmaceuticals_receives_two_us_patents_for_mugard_100609-2/</loc>
		<lastmod>2009-06-10T16:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/monosol_rx_wins_fda_acceptance_for_ondansetron_orally_dissolving_film_strip_100609-2/</loc>
		<lastmod>2009-06-10T17:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ncircle_hitrust_collaborate_to_deliver_innovative_saas_offering_090611-2/</loc>
		<lastmod>2009-06-11T08:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pharmasurveyor_advanced_drug_safety_service_connects_to_microsoft_healthvault_090611-2/</loc>
		<lastmod>2009-06-11T08:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/watson_files_anda_for_generic_mucinex_d_110609-2/</loc>
		<lastmod>2009-06-11T13:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/wyeth_provides_phaseiii_updates_for_pneumococcal_drug_090611-2/</loc>
		<lastmod>2009-06-11T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer_reports_positive_results_for_rheumatoid_arthritis_090611-2/</loc>
		<lastmod>2009-06-11T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofiaventis_regeneron_provides_phaseii_results_for_aflibercept_090611-2/</loc>
		<lastmod>2009-06-11T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/neurim_provides_phaseiii_data_for_circadin_drug_for_insomnia_090611-2/</loc>
		<lastmod>2009-06-11T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/staar_receives_fda_clearance_for_epiphany_injector_system_090611-2/</loc>
		<lastmod>2009-06-11T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gtxs_phaseii_cancer_cachexia_trial_meets_primary_endpoint_090611-2/</loc>
		<lastmod>2009-06-11T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mds_reports_total_revenue_of_282_million_for_q2_fiscal_2009_090611-2/</loc>
		<lastmod>2009-06-11T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medivation_completes_enrollment_in_phaseiii_alzheimers_trial_090611-2/</loc>
		<lastmod>2009-06-11T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/orexigen_signs_licensing_agreement_with_gsk_090611-2/</loc>
		<lastmod>2009-06-11T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/regeneron_signs_two_royalty_agreements_with_novartis_090611-2/</loc>
		<lastmod>2009-06-11T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck_terminates_research_collaboration_license_agreement_090611-2/</loc>
		<lastmod>2009-06-11T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/jubilant_to_form_drug_development_collaboration_with_endo_pharmaceuticals_090611-2/</loc>
		<lastmod>2009-06-11T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hgs_provides_positive_results_for_clinical_trial_of_lupus_drug_090611-2/</loc>
		<lastmod>2009-06-11T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/xenon_signs_collaboration_agreement_with_merck_090611-2/</loc>
		<lastmod>2009-06-11T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/emergent_wins_fda_approval_extending_shelf_life_of_biothrax_to_4_years_110609-2/</loc>
		<lastmod>2009-06-11T14:04:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_advisory_committee_votes_for_zyprexa_for_two_adolescent_indications_110609-2/</loc>
		<lastmod>2009-06-11T14:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dow_launches_global_business_and_innovation_hub_in_asia_pacific_110609-2/</loc>
		<lastmod>2009-06-11T16:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dow_unveils_dow_coatings_materials_110609-2/</loc>
		<lastmod>2009-06-11T16:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/meridios_earns_nationwide_cms_qualified_registry_status_090612-2/</loc>
		<lastmod>2009-06-12T08:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/emergent_meets_fda_for_review_on_anthrax_vaccine_120609-2/</loc>
		<lastmod>2009-06-12T11:15:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/via_pharmaceuticals_meets_fda_on_cardiovascular_drug_120609-2/</loc>
		<lastmod>2009-06-12T11:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/polymedix_secures_923000_sbir_grant_090612-2/</loc>
		<lastmod>2009-06-12T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novo_nordisk_cautions_consumers_about_stolen_insulin_090612-3/</loc>
		<lastmod>2009-06-12T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck_declaration_in_response_to_fdas_update_on_singulair_090612-2/</loc>
		<lastmod>2009-06-12T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biosense_to_fund_clinical_trial_of_atrial_fibrillation_090612-2/</loc>
		<lastmod>2009-06-12T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/baxter_ready_for_fullscale_production_of_a_h1n1_vaccine_090612-2/</loc>
		<lastmod>2009-06-12T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hemispherx_biken_expands_production_capacity_for_swine_flu_vaccines_090612-2/</loc>
		<lastmod>2009-06-12T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bayer_completes_phaseii_on_bay_949172_for_alzheimers_disease_090612-2/</loc>
		<lastmod>2009-06-12T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abraxis_bioscience_launches_abraxane_in_china_090612-2/</loc>
		<lastmod>2009-06-12T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi_pasteur_to_facilitate_public_health_efforts_090612-2/</loc>
		<lastmod>2009-06-12T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk_initiates_development_of_new_candidate_vaccine_for_h1n1_influenza_vaccine_090612-2/</loc>
		<lastmod>2009-06-12T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis_produces_first_batch_of_swine_flu_vaccine_090612-2/</loc>
		<lastmod>2009-06-12T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bristolmyers_squibb_reports_consistent_safety_effectiveness_for_rheumatoid_arthritis_trial_090612-2/</loc>
		<lastmod>2009-06-12T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/combinatorx_provides_positive_result_for_knee_osteoarthritis_trial_090612-2/</loc>
		<lastmod>2009-06-12T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cumberland_receives_fda_approval_for_caldolor_120609-2/</loc>
		<lastmod>2009-06-12T14:10:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/boehringer_ingelheim_investigational_combination_witnesses_positive_results_090614-2/</loc>
		<lastmod>2009-06-14T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/petition_for_ldt_regulation_subject_of_industry_debate_090615-2/</loc>
		<lastmod>2009-06-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hitsp_initiates_harmonization_process_for_use_of_electronic_health_records_090615-2/</loc>
		<lastmod>2009-06-15T08:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/virtualhealth_partners_silk_to_provide_revenue_recovery_software_090615-2/</loc>
		<lastmod>2009-06-15T08:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/omnicell_workflowrx_to_boost_pharmacy_efficiency_090615-2/</loc>
		<lastmod>2009-06-15T08:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tcs_launches_business_intelligence_software_for_hospitals_healthcare_providers_090615-2/</loc>
		<lastmod>2009-06-15T08:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/jazz_pharmaceuticals_jzp6_to_reduce_symptoms_of_fibromyalgia_090615-2/</loc>
		<lastmod>2009-06-15T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/protein_sciences_initiates_manufacturing_of_h1n1_vaccine_090615-2/</loc>
		<lastmod>2009-06-15T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eli_lilly_announces_new_drug_discovery_initiative_090615-3/</loc>
		<lastmod>2009-06-15T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aeterna_to_present_safety_study_data_for_phaseiii_program_in_bph_090615-3/</loc>
		<lastmod>2009-06-15T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/neostem_signs_development_agreement_with_enhance_biomedical_090615-2/</loc>
		<lastmod>2009-06-15T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/proteolix_pr957_to_prevent_disease_progression_in_rheumatoid_arthritis_090615-2/</loc>
		<lastmod>2009-06-15T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk_dr_reddys_enter_strategic_alliance_090615-2/</loc>
		<lastmod>2009-06-15T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/synta_gsk_to_end_elesclomol_collaboration_agreement_090615-2/</loc>
		<lastmod>2009-06-15T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/qlt_provides_results_of_mont_blanc_study_090615-2/</loc>
		<lastmod>2009-06-15T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sinovac_completes_construction_of_h1n1_virus_seed_bank_090615-2/</loc>
		<lastmod>2009-06-15T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/boehringer_ingelheim_vitae_collaborate_for_development_of_betasecretase_inhibitors_090615-2/</loc>
		<lastmod>2009-06-15T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/transdel_provides_update_on_phaseiii_study_090615-2/</loc>
		<lastmod>2009-06-15T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kowa_releases_topline_results_for_dyslipidemia_trial_090615-2/</loc>
		<lastmod>2009-06-15T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ipsogen_raises_e25m_reserved_capital_090615-2/</loc>
		<lastmod>2009-06-15T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mds_nordion_karpov_institute_collaborate_for_global_nuclear_medicine_market_090615-2/</loc>
		<lastmod>2009-06-15T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/misonix_purchases_patents_from_prorhythm_150609-2/</loc>
		<lastmod>2009-06-15T16:50:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_accept_final_section_of_nda_filing_for_lucassin_120609-2/</loc>
		<lastmod>2009-06-15T16:53:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genzyme_obtains_european_approval_for_renvela_150609-2/</loc>
		<lastmod>2009-06-15T16:56:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/socma_announces_five_new_members_in_second_quarter_150609-2/</loc>
		<lastmod>2009-06-15T17:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/urac_carf_international_launches_new_survey_tool_090616-2/</loc>
		<lastmod>2009-06-16T08:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/autonomy_gcb_to_safely_capture_manage_patients_records_090616-2/</loc>
		<lastmod>2009-06-16T08:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/noteworthy_medical_systems_launches_netpay_090616-2/</loc>
		<lastmod>2009-06-16T08:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pluristem_recieves_european_approval_for_clinical_trial_of_plx_pad_160609-2/</loc>
		<lastmod>2009-06-16T12:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ptc_receives_26m_government_grants_160609-2/</loc>
		<lastmod>2009-06-16T12:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/osi_pharmaceuticals_receives_acceptance_of_tarceva_supplemental_nda_by_fda_160609-2/</loc>
		<lastmod>2009-06-16T13:12:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/us_patent_office_confirms_validity_of_claims_for_palomars_hair_removal_patent_160609-2/</loc>
		<lastmod>2009-06-16T13:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/molecular_insight_declares_clinical_data_on_prostate_cancer_trial_090616-2/</loc>
		<lastmod>2009-06-16T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alexza_to_acquire_symphony_allegro_090616-2/</loc>
		<lastmod>2009-06-16T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/matrixx_initiatives_voluntarily_withdraws_zicam_products_090616-2/</loc>
		<lastmod>2009-06-16T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbott_initiates_spirit_prime_trial_090616-2/</loc>
		<lastmod>2009-06-16T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genzyme_temporarily_stops_production_at_allston_plant_090616-2/</loc>
		<lastmod>2009-06-16T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/peregrine_releases_results_for_brain_cancer_trial_090616-2/</loc>
		<lastmod>2009-06-16T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/morphosys_extends_alliance_with_scheringplough_090616-2/</loc>
		<lastmod>2009-06-16T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cenerx_biopharma_completes_9m_financing_090616-2/</loc>
		<lastmod>2009-06-16T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/qiagen_linkmed_sign_agreement_to_transfer_distribution_rights_090616-2/</loc>
		<lastmod>2009-06-16T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/healthpoint_begins_phaseii_clinical_trial_enrollment_for_venous_leg_ulcers_090616-2/</loc>
		<lastmod>2009-06-16T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/macrogenics_lilly_reaches_targeted_patient_enrollment_in_protege_trial_090616-2/</loc>
		<lastmod>2009-06-16T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nuvo_covidien_sign_development_agreement_090616-2/</loc>
		<lastmod>2009-06-16T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alpharx_gaia_provides_update_on_gai122_090616-2/</loc>
		<lastmod>2009-06-16T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cenerx_receives_right_to_develop_market_cxb909_090616-2/</loc>
		<lastmod>2009-06-16T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/three_rivers_presents_positive_results_for_phaseiii_hepatitis_c_trial_090616-2/</loc>
		<lastmod>2009-06-16T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/clarient_launches_new_gene_mutation_test_090616-2/</loc>
		<lastmod>2009-06-16T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/thomson_reuters_collaborates_with_research4life_090616-2/</loc>
		<lastmod>2009-06-16T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lonza_elusys_sign_manufacturing_agreement_090616-2/</loc>
		<lastmod>2009-06-16T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bayer_completes_sulfuric_acid_plant_160609-2/</loc>
		<lastmod>2009-06-16T16:27:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/extended_review_for_gsks_arzerra_160609-2/</loc>
		<lastmod>2009-06-16T16:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/curagen_provides_update_on_phaseii_cancer_trial_090617-2/</loc>
		<lastmod>2009-06-17T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nxstage_signs_distribution_agreement_with_gambro_090617-2/</loc>
		<lastmod>2009-06-17T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/johnson__johnson_receives_regulatory_clearance_for_acquisition_of_cougar_090617-2/</loc>
		<lastmod>2009-06-17T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/watson_signs_definitive_agreement_to_acquire_arrow_group_090617-2/</loc>
		<lastmod>2009-06-17T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/epeius_rexing_receives_fast_track_designation_from_fda_090617-2/</loc>
		<lastmod>2009-06-17T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cepheid_releases_improved_test_for_bcrabl_090617-2/</loc>
		<lastmod>2009-06-17T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/antigenics_gsk_initiates_phaseiii_malaria_trial_090617-2/</loc>
		<lastmod>2009-06-17T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/access_signs_two_drug_delivery_collaboration_agreements_090617-2/</loc>
		<lastmod>2009-06-17T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tibotec_global_alliance_for_tb_sign_collaboration_agreement_090617-2/</loc>
		<lastmod>2009-06-17T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/xanodyne_receives_fda_approval_for_zipsor_liquid_filled_capsules_090617-2/</loc>
		<lastmod>2009-06-17T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/neuromed_sells_us_rights_of_exalgo_to_covidien_090617-3/</loc>
		<lastmod>2009-06-17T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/crucell_acquires_xcellerexs_bioproduction_line_090617-3/</loc>
		<lastmod>2009-06-17T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/clavis_positive_results_for_phaseii_leukaemia_trial_090617-3/</loc>
		<lastmod>2009-06-17T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mylan_receives_fda_approval_for_additional_strength_of_generic_restoril_170609-2/</loc>
		<lastmod>2009-06-17T17:08:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/strativas_partner_bioalliance_pharma_submits_nda_to_fda_170609-2/</loc>
		<lastmod>2009-06-17T17:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cytokinetics_initiates_clinical_trial_of_ck2017357_090618-2/</loc>
		<lastmod>2009-06-18T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/seattle_genetics_initiates_phaseii_lymphoma_trial_090618-2/</loc>
		<lastmod>2009-06-18T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sec_declares_pfizer_registration_statement_effective_for_acquisition_of_wyeth_090618-2/</loc>
		<lastmod>2009-06-18T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/takeda_launches_two_new_dosage_combination_of_blopress_diuretic_090618-2/</loc>
		<lastmod>2009-06-18T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/paladin_labs_signs_exclusive_agreement_with_sylphar_090618-2/</loc>
		<lastmod>2009-06-18T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/antares_pharma_presents_safety_study_of_libigel_090618-2/</loc>
		<lastmod>2009-06-18T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amt_glybera_shows_longterm_health_benefits_090618-2/</loc>
		<lastmod>2009-06-18T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/allergan_receives_fda_approval_for_ozurdex_090618-2/</loc>
		<lastmod>2009-06-18T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis_receives_fda_approval_for_ilaris_090618-2/</loc>
		<lastmod>2009-06-18T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/manhattan_provides_corporate_update_on_pediculosis_drug_090618-2/</loc>
		<lastmod>2009-06-18T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hartest_reports_preliminary_results_for_fiscal_2009_090618-2/</loc>
		<lastmod>2009-06-18T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/oculus_reports_preliminary_results_of_microcyn_hydrogel_formulation_090619-2/</loc>
		<lastmod>2009-06-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bioline_commences_phase_iii_trial_of_bl5010_090619-2/</loc>
		<lastmod>2009-06-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kv_pharmaceutical_signs_licensing_agreement_with_gedeon_richter_090619-2/</loc>
		<lastmod>2009-06-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cephalon_provides_clinical_update_on_lestaurtinib_090619-2/</loc>
		<lastmod>2009-06-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mayo_clinic_reports_data_on_prostate_cancer_study_with_ipilimumab_090619-2/</loc>
		<lastmod>2009-06-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/forest_laboratories_positive_results_from_two_phaseiii_trials_of_ceftaroline_090619-2/</loc>
		<lastmod>2009-06-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/china_medical_announces_unaudited_preliminary_results_for_fiscal_2008_090619-2/</loc>
		<lastmod>2009-06-18T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vical_progresses_rapidresponse_dna_vaccine_platform_190609-2/</loc>
		<lastmod>2009-06-19T14:11:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_remove_clinical_hold_from_aastrom_phase_ii_impact_dcm_clinical_trial_190609-2/</loc>
		<lastmod>2009-06-19T14:21:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/innocoll_declares_findings_from_its_three_phase_2_clinical_trials_of_collarx_190609-2/</loc>
		<lastmod>2009-06-19T14:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/socma_joins_drug_supply_chain_consortium_190609-2/</loc>
		<lastmod>2009-06-19T15:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/china_medical_reports_unaudited_preliminary_financial_results_for_q4_and_fiscal_2008_190609-2/</loc>
		<lastmod>2009-06-19T16:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hgs_completes_enrollment_in_phase_2b_albuferon_trail_190609-2/</loc>
		<lastmod>2009-06-19T16:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_grants_the_medicines_company_pediatric_exclusivity_190609-2/</loc>
		<lastmod>2009-06-19T16:26:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gtc_secures_123m_in_funding_190609-2/</loc>
		<lastmod>2009-06-19T16:41:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hospira_receives_favorable_court_decision_on_eloxatin_190609-2/</loc>
		<lastmod>2009-06-19T16:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cannabis_science_to_file_patent_for_cannabis_processing_and_drug_delivery_systems_190609-2/</loc>
		<lastmod>2009-06-19T17:29:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biolinerx_declares_new_results_for_antipsychotic_drug_090621-2/</loc>
		<lastmod>2009-06-20T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/perceptive_launches_eclinical_suite_090622-2/</loc>
		<lastmod>2009-06-21T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sparta_systems_launches_trackwise_clinical_quality_management_solution_090622-2/</loc>
		<lastmod>2009-06-21T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/emisphere_signs_research_agreement_with_syracuse_university_090622-2/</loc>
		<lastmod>2009-06-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cti_reports_pixantrone_clinical_studies_090622-2/</loc>
		<lastmod>2009-06-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ids_posts_preliminary_revenues_of_gbp249_million_in_fiscal_2009_090622-2/</loc>
		<lastmod>2009-06-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/combimatrix_updates_its_lawsuit_with_national_union_and_36_million_judgment_090622-2/</loc>
		<lastmod>2009-06-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck_kgaa_initiates_phaseiii_study_of_stimuvax_090622-2/</loc>
		<lastmod>2009-06-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/neovacs_to_initiates_phaseii_study_of_tnf_kinoid_090622-2/</loc>
		<lastmod>2009-06-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/china_sky_one_medical_receives_sfda_approval_for_pain_relief_drugs_090622-2/</loc>
		<lastmod>2009-06-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cordex_signs_european_development_partnership_for_atpotent_090622-2/</loc>
		<lastmod>2009-06-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/trubion_extends_research_period_with_wyeth_090622-2/</loc>
		<lastmod>2009-06-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/brahms_cezanne_lumiphore_form_partnership_090622-2/</loc>
		<lastmod>2009-06-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amicus_initiates_phaseiii_amigal_trial_090622-2/</loc>
		<lastmod>2009-06-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/china_pharma_receives_sfda_approval_for_rosuvastatin_090622-2/</loc>
		<lastmod>2009-06-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/enzon_initiates_phaseii_cancer_trial_090622-2/</loc>
		<lastmod>2009-06-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biomodels_helps_actigenix_receive_fda_approval_090622-2/</loc>
		<lastmod>2009-06-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/neurogesx_astellas_sign_agreement_for_qutenza_090622-2/</loc>
		<lastmod>2009-06-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biogen_initiates_phaseiii_multiple_sclerosis_trial_090622-2/</loc>
		<lastmod>2009-06-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_extends_review_period_for_eurand_zenpep_090622-2/</loc>
		<lastmod>2009-06-21T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/health_canada_is_warning_canadians_not_to_use_clean_testing_hiv_home_test_kit_or_any_home_hiv_test_kit_090622-2/</loc>
		<lastmod>2009-06-22T12:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/phase_forward_launches_empirica_study_solution_090623-2/</loc>
		<lastmod>2009-06-22T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/osiris_reports_interim_results_for_phaseii_prochymal_trial_090623-2/</loc>
		<lastmod>2009-06-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biosante_pharmaceuticals_files_nda_for_elestrin_in_israel_090623-2/</loc>
		<lastmod>2009-06-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk_chroma_therapeutics_form_alliance_090623-2/</loc>
		<lastmod>2009-06-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cerulean_signs_license_agreement_with_calando_090623-2/</loc>
		<lastmod>2009-06-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nucyntatm_now_available_for_pain_relief_090623-2/</loc>
		<lastmod>2009-06-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cytopia_files_investigational_new_drug_application_for_cyt387_090623-2/</loc>
		<lastmod>2009-06-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ym_biosciences_daiichisankyo_initiate_phaseii_lung_cancer_trial_090623-2/</loc>
		<lastmod>2009-06-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/spherix_initiates_production_of_tagatose_090623-2/</loc>
		<lastmod>2009-06-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/javelin_completes_open_label_safety_study_of_dyloject_090623-2/</loc>
		<lastmod>2009-06-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/takeda_initiates_tak536_phaseiii_clinical_trials_in_japan_090623-2/</loc>
		<lastmod>2009-06-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/resolvyx_initiates_clinical_trial_of_rx10001_090623-2/</loc>
		<lastmod>2009-06-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/covance_initiates_integrated_radiolabeled_clinical_pharmacology_studies_090623-2/</loc>
		<lastmod>2009-06-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/labcorp_signs_agreement_to_acquire_monogram_biosciences_090623-2/</loc>
		<lastmod>2009-06-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/baxter_to_acquire_hemofiltration_product_line_from_edwards_lifesciences_090623-2/</loc>
		<lastmod>2009-06-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/octoplus_opens_new_gmp_manufacturing_facility_090623-2/</loc>
		<lastmod>2009-06-22T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk_provides_regulatory_update_on_rezonic_090624-2/</loc>
		<lastmod>2009-06-23T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cell_therapeutics_completes_nda_submission_for_pixantrone_090624-2/</loc>
		<lastmod>2009-06-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/atox_bio_fasttrack_drugs__biologics_sign_collaboration_agreement_090624-2/</loc>
		<lastmod>2009-06-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/oculus_confirms_effectiveness_of_microcyn_at_inactivating_h1n1_090624-2/</loc>
		<lastmod>2009-06-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/trilink_signs_sales_license_agreement_with_glen_research_090624-2/</loc>
		<lastmod>2009-06-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/takeda_completes_acquisition_of_idm_pharma_090624-2/</loc>
		<lastmod>2009-06-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/neuralstem_signs_agreement_with_china_medical_university_090624-2/</loc>
		<lastmod>2009-06-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/new_zealand_government_authorizes_lct_diabecell_clinical_trial_090624-2/</loc>
		<lastmod>2009-06-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/celsci_files_patent_application_for_leaps_immune_therapy_drugs_090624-2/</loc>
		<lastmod>2009-06-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/matrixx_confirms_voluntary_recall_of_zicam_090624-2/</loc>
		<lastmod>2009-06-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/glenmarks_melogliptin_to_enter_phaseiii_trials_090624-2/</loc>
		<lastmod>2009-06-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/synthon_files_anda_for_generic_version_of_xyzal_solution_090624-2/</loc>
		<lastmod>2009-06-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/conatus_pharmaceuticals_initiates_second_phaseii_hepatitis_trial_090624-2/</loc>
		<lastmod>2009-06-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/immunocellular_signs_manufacturing_agreement_with_formatech_090624-2/</loc>
		<lastmod>2009-06-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/watson_wins_fda_approval_for_levonorgestrel_090624-2/</loc>
		<lastmod>2009-06-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/actavis_launches_finasteride_as_patent_expires_in_france_090624-2/</loc>
		<lastmod>2009-06-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/oncogenex_completes_amendment_to_phaseiii_special_protocol_assessment_for_ogx011_090624-2/</loc>
		<lastmod>2009-06-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/spherix_reports_positive_results_for_phaseii_diabetes_study_090624-2/</loc>
		<lastmod>2009-06-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/diagenic_signs_deal_with_merz_gains_access_to_mci_biomarkers_090624-2/</loc>
		<lastmod>2009-06-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gentiva_health_services_acquires_louisiana_home_health_agency_090624-2/</loc>
		<lastmod>2009-06-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/acusphere_amends_terms_of_license_agreement_with_cephalon_090624-2/</loc>
		<lastmod>2009-06-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/luminex_announces_executive_appointments_090624-2/</loc>
		<lastmod>2009-06-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/celsis_reports_preliminary_results_for_fiscal_2009_090624-2/</loc>
		<lastmod>2009-06-23T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dcom_selects_allscripts_electronic_health_record_practice_management_solution_090625-2/</loc>
		<lastmod>2009-06-24T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/intercell_supports_japanese_encephalitis_vaccination_recommendations_for_ixiaro_090625-2/</loc>
		<lastmod>2009-06-24T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/protalix_initiates_home_care_treatment_program_for_gaucher_patients_090625-2/</loc>
		<lastmod>2009-06-24T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sandoz_receives_approval_for_japanese_biosimilar_090625-2/</loc>
		<lastmod>2009-06-24T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/orasure_provides_update_on_clinical_development_programs_090625-2/</loc>
		<lastmod>2009-06-24T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ligand_signs_license_agreement_with_paringenix_090625-2/</loc>
		<lastmod>2009-06-24T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer_reports_positive_results_for_phaseiii_sutent_trial_090625-2/</loc>
		<lastmod>2009-06-24T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/insmed_presents_result_of_phaseii_iplex_trial_090625-2/</loc>
		<lastmod>2009-06-24T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/shamrock_receives_sbir_grant_to_develop_waxs_090625-2/</loc>
		<lastmod>2009-06-24T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/antigenics_reports_expansion_of_phaseii_glioma_trial_090625-2/</loc>
		<lastmod>2009-06-24T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/oxigene_initiates_phaseii_trial_of_zybrestat_090625-2/</loc>
		<lastmod>2009-06-24T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/zila_signs_merger_agreement_with_tolmar_090625-2/</loc>
		<lastmod>2009-06-24T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/onglyza_obtains_positive_opinion_from_chmp_090625-2/</loc>
		<lastmod>2009-06-24T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/teva_completes_enrollment_in_second_oral_laquinimod_phaseiii_trial_090625-2/</loc>
		<lastmod>2009-06-24T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/inotek_pharmaceuticals_reports_positive_glaucoma_study_results_090625-2/</loc>
		<lastmod>2009-06-24T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis_reports_positive_result_for_phaseii_trial_of_afinitor_sandostatin_lar_090625-2/</loc>
		<lastmod>2009-06-24T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chembio_diagnostic_wins_three_year_3_million_grant_from_nih_090625-2/</loc>
		<lastmod>2009-06-24T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/galderma_azzalure_receives_marketing_authorization_in_germany_090626-2/</loc>
		<lastmod>2009-06-25T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/immucor_to_respond_to_fda_notice_090626-2/</loc>
		<lastmod>2009-06-25T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/radiant_research_to_initiate_h1n1_vaccine_trials_090626-2/</loc>
		<lastmod>2009-06-25T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chmp_adopts_positive_opinion_for_aztreonam_lysine_090626-2/</loc>
		<lastmod>2009-06-25T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ortho_clinical_diagnostics_opens_manufacturing_facility_in_wales_090626-2/</loc>
		<lastmod>2009-06-25T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/laboratoires_pierre_javlor_receives_positive_opinion_from_chmp_090626-2/</loc>
		<lastmod>2009-06-25T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/miraculins_signs_agreements_with_diagnostic_technologies_dtl_ciirdf_090626-2/</loc>
		<lastmod>2009-06-25T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk_provides_update_on_seretide_litigation_090626-2/</loc>
		<lastmod>2009-06-25T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aclasta_gets_approval_in_eu_to_treat_osteoporosis_090626-2/</loc>
		<lastmod>2009-06-25T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/boehringer_ingelheim_receives_positive_recommendation_for_mirapexin_090626-2/</loc>
		<lastmod>2009-06-25T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/takeda_receives_fda_complete_response_letter_for_alogliptin_090627-2/</loc>
		<lastmod>2009-06-26T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biovest_biovaxid_now_available_in_europe_090628-2/</loc>
		<lastmod>2009-06-27T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/immunocellular_receives_japanese_patent_for_ict109_090629-2/</loc>
		<lastmod>2009-06-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bayer_schering_signs_license_agreement_with_celera_090629-2/</loc>
		<lastmod>2009-06-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cytrx_reports_update_for_phase_2_leukemia_trial_with_tamibarotene_090629-2/</loc>
		<lastmod>2009-06-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/yaupon_completes_patient_enrollment_for_phaseii_study_of_clearazide_090629-2/</loc>
		<lastmod>2009-06-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/achillion_initiates_trail_dosing_of_ach1625_090629-2/</loc>
		<lastmod>2009-06-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/acelrx_declares_positive_phaseii_results_for_arx01_sufentanil_nanotabs_090629-2/</loc>
		<lastmod>2009-06-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/crystalgenomics_palkion_initiate_preclinical_studies_for_anemia_drug_090629-2/</loc>
		<lastmod>2009-06-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sinovac_aquires_revised_approvals_for_panflu_090629-2/</loc>
		<lastmod>2009-06-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/feraheme_expects_fda_decision_on_feraheme_nda_soon_090629-2/</loc>
		<lastmod>2009-06-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vitas_signs_national_agreement_with_unicare_090629-2/</loc>
		<lastmod>2009-06-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/zebinix_shows_longterm_reduction_in_seizure_frequency_090629-2/</loc>
		<lastmod>2009-06-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mylan_signs_collaboration_agreement_with_biocon_090629-2/</loc>
		<lastmod>2009-06-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vantia_reports_positive_results_for_phaseiia_nocturia_trial_090629-2/</loc>
		<lastmod>2009-06-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/rexahn_signs_development_commercialization_agreement_with_the_partner_090629-2/</loc>
		<lastmod>2009-06-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abraxane_gets_approval_for_metastatic_breast_cancer_treatment_in_quebec_090629-2/</loc>
		<lastmod>2009-06-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/access_launches_mugard_in_greece_090629-2/</loc>
		<lastmod>2009-06-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amarillo_cytopharm_intiates_enrollment_for_hepatitisc_study_090629-2/</loc>
		<lastmod>2009-06-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hospira_receives_fda_approval_for_azithromycin_for_injection_090629-2/</loc>
		<lastmod>2009-06-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/teva_antares_receives_fda_approval_for_needlefree_injector_090629-2/</loc>
		<lastmod>2009-06-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis_initiates_phaseiii_clinical_study_of_nva237_090629-2/</loc>
		<lastmod>2009-06-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/juvaris_signs_strategic_collaboration_with_adi_090629-2/</loc>
		<lastmod>2009-06-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cordex_completes_production_of_atpace_clinical_trial_material_090629-2/</loc>
		<lastmod>2009-06-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/evotec_completes_first_phasei_study_with_evt_401_090629-2/</loc>
		<lastmod>2009-06-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/morphosys_to_receive_payment_in_therapeutic_antibody_program_090629-2/</loc>
		<lastmod>2009-06-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ym_biosciences_subsidiary_resolves_arbitration_with_oncoscience_090629-2/</loc>
		<lastmod>2009-06-28T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/siemens_healthcare_appoints_michael_reitermann_as_new_ceo_us_operations_090629-2/</loc>
		<lastmod>2009-06-29T12:52:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/virginia_mason_to_implement_carefxs_fusionfx_solution_suite_090630-2/</loc>
		<lastmod>2009-06-29T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biosante_cell_genesys_sign_merger_agreement_090630-2/</loc>
		<lastmod>2009-06-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vical_posts_100_response_in_preclinical_results_for_h1_influenza_vaccine_090630-2/</loc>
		<lastmod>2009-06-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/prolor_receives_two_us_patents_090630-2/</loc>
		<lastmod>2009-06-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/myriad_genetics_posts_preliminary_results_for_q409_090630-2/</loc>
		<lastmod>2009-06-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cephalon_submits_supplemental_new_drug_application_for_nuvigil_090630-2/</loc>
		<lastmod>2009-06-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/xenoport_reports_positive_results_from_arbaclofen_placarbil_trial_090630-2/</loc>
		<lastmod>2009-06-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/golden_meditech_reports_fiscal_200809_results_090630-2/</loc>
		<lastmod>2009-06-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca_pozen_submit_new_drug_application_for_pn400_090630-2/</loc>
		<lastmod>2009-06-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/spanish_government_novavax_sign_license_agreement_for_vaccine_technology_090630-2/</loc>
		<lastmod>2009-06-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/wyeth_catalyst_sign_agreement_to_develop_commercialize_factor_viia_products_090630-2/</loc>
		<lastmod>2009-06-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofiaventis_presents_new_rd_modelproject_090630-2/</loc>
		<lastmod>2009-06-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/peregrine_completes_patient_enrollment_in_bavituximab_trial_090630-2/</loc>
		<lastmod>2009-06-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amira_reports_positive_phase_1_data_for_am211_090630-2/</loc>
		<lastmod>2009-06-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis_receives_complete_response_letter_from_fda_for_menveo_090630-2/</loc>
		<lastmod>2009-06-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/efsa_issues_safety_statement_for_use_of_chromium_picolinate_090630-2/</loc>
		<lastmod>2009-06-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chelsea_therapeutics_completes_enrollment_in_phaseiii_trial_of_droxidopa_090630-2/</loc>
		<lastmod>2009-06-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biogaia_signs_agreement_with_semper_for_ors_090630-2/</loc>
		<lastmod>2009-06-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cytrx_files_report_with_fda_in_response_to_partial_clinical_hold_on_arimoclomol_090630-2/</loc>
		<lastmod>2009-06-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer_discontinues_phaseiii_trial_of_sutent_090630-2/</loc>
		<lastmod>2009-06-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/calixa_initiates_phase_2_clinical_trial_for_uti_090630-2/</loc>
		<lastmod>2009-06-29T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/repros_therapeutics_provides_update_for_proellex_clinical_program_090701-2/</loc>
		<lastmod>2009-06-30T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amags_feraheme_wins_fda_approval_090701-2/</loc>
		<lastmod>2009-06-30T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/teva_receives_fda_approval_for_oral_contraceptive_090701-2/</loc>
		<lastmod>2009-06-30T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/iressa_receives_marketing_authorisation_in_europe_090701-2/</loc>
		<lastmod>2009-06-30T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roche_launches_new_program_to_ease_tamiflu_access_090701-2/</loc>
		<lastmod>2009-06-30T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/huhhot_xinheng_baide_acquires_raw_bovine_serum_collection_center_in_china_090701-2/</loc>
		<lastmod>2009-06-30T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/provectus_completes_patient_enrollment_in_phase_2_atopic_dermatitis_trial_090701-2/</loc>
		<lastmod>2009-06-30T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/graceway_signs_acquisition_license_agreement_with_pfizer_090701-2/</loc>
		<lastmod>2009-06-30T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/morphotek_signs_collaboration_agreement_with_synageva_090701-2/</loc>
		<lastmod>2009-06-30T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biogen_idec_acorda_sign_collaboration_agreement_for_fampridinesr_090701-2/</loc>
		<lastmod>2009-06-30T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/inc_research_acquires_mds_pharma_services_phase_iiiv_operations_090701-2/</loc>
		<lastmod>2009-06-30T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sepracor_provides_update_on_clinical_trials_for_sep225289_lunesta_090701-2/</loc>
		<lastmod>2009-06-30T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/shire_provides_results_for_phase_3b_vyvanse_study_090701-2/</loc>
		<lastmod>2009-06-30T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/combinatorx_signs_merger_agreement_with_neuromed_090701-2/</loc>
		<lastmod>2009-06-30T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/scheringplough_presents_phase_ii_and_iii_data_for_corifollitropin_alfa_090701-2/</loc>
		<lastmod>2009-06-30T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/emdeon_acquires_erx_network_090702-2/</loc>
		<lastmod>2009-07-01T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/omega_medical_selects_allscripts_practice_management_payerpath_solution_090702-2/</loc>
		<lastmod>2009-07-01T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/morphosys_signs_agreement_with_university_of_melbourne_090702-2/</loc>
		<lastmod>2009-07-01T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lundbeck_presents_positive_results_for_depressive_disorder_phase_ii_study_090702-2/</loc>
		<lastmod>2009-07-01T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eisai_provides_update_on_aricept_090702-2/</loc>
		<lastmod>2009-07-01T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk_extends_product_portfolio_in_middle_east_north_africa_090702-2/</loc>
		<lastmod>2009-07-01T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/prasco_signs_distribution_supply_agreement_with_axcan_pharma_090702-2/</loc>
		<lastmod>2009-07-01T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/acura_king_receive_fda_complete_response_letter_for_acurox_090702-2/</loc>
		<lastmod>2009-07-01T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lixte_presents_positive_results_for_lb12_trial_090702-2/</loc>
		<lastmod>2009-07-01T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/winner_medical_signs_purcotton_sales_agreement_090702-2/</loc>
		<lastmod>2009-07-01T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alcon_discontinues_trials_for_anecortave_acetate_090702-2/</loc>
		<lastmod>2009-07-01T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/us_to_provide_antiviral_medication_to_latin_america_caribbean_090702-2/</loc>
		<lastmod>2009-07-01T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/oncolytics_completes_patient_enrollment_for_cancer_trial_090702-2/</loc>
		<lastmod>2009-07-01T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/jj_elan_sign_agreement_for_alzheimers_immunotherapy_program_090702-2/</loc>
		<lastmod>2009-07-01T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/myriad_genetics_spins_off_research_pharmaceutical_business_090702-2/</loc>
		<lastmod>2009-07-01T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genentech_reports_positive_phaseiii_lucentis_study_090702-2/</loc>
		<lastmod>2009-07-01T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/connectyx_signs_distribution_agreement_with_healthy_directions_090702-2/</loc>
		<lastmod>2009-07-01T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/interleukin_divests_alan_james_group_090702-2/</loc>
		<lastmod>2009-07-01T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/governor_rell_bans_house_bill_5021_090702-2/</loc>
		<lastmod>2009-07-01T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi_aventis_receives_fda_approval_for_multaq_020709-2/</loc>
		<lastmod>2009-07-02T17:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bayer_files_patent_infringement_lawsuit_against_teva_020709-2/</loc>
		<lastmod>2009-07-02T17:19:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novo_nordisk_receives_marketing_authorisation_for_victoza_090703-2/</loc>
		<lastmod>2009-07-02T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/glaxosmithkline_discontinues_development_of_remogliflozin_090703-2/</loc>
		<lastmod>2009-07-02T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biocis_reports_positive_phase_iia_clinical_results_in_atopic_dermatitis_090703-2/</loc>
		<lastmod>2009-07-02T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cougar_reports_successful_completion_of_jj_initial_tender_offer_090703-2/</loc>
		<lastmod>2009-07-02T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bioinvent_thrombogenics_initiate_patients_enrollment_for_deep_vein_thrombosis_090703-2/</loc>
		<lastmod>2009-07-02T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/adaltis_secures_court_order_for_creditor_protection_under_ccaa_090703-2/</loc>
		<lastmod>2009-07-02T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amp_principles_for_health_care_reform_090704-2/</loc>
		<lastmod>2009-07-03T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/spectrum_pharmaceuticals_gets_fda_response_for_zevalin_090705-2/</loc>
		<lastmod>2009-07-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_warns_consumers_on_hardcore_energize_bullet_new_whey_liquid_products_090705-2/</loc>
		<lastmod>2009-07-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/arthrovision_accepts_court_decision_abandons_german_part_of_osteoarthritis_090705-2/</loc>
		<lastmod>2009-07-04T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/metcare_selects_eclinicalworks_electronic_medical_records_solution_090706-2/</loc>
		<lastmod>2009-07-05T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/caremedic_cincom_sign_oem_technology_partnership_for_healthcare_solution_090706-2/</loc>
		<lastmod>2009-07-05T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/new_smallandmediumsized_enterprises_sign_two_projects_with_ti_pharma_090706-2/</loc>
		<lastmod>2009-07-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofiaventis_provides_results_for_lantus_study_090706-2/</loc>
		<lastmod>2009-07-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/oxford_biomedica_provides_fda_response_update_on_trovax_090706-2/</loc>
		<lastmod>2009-07-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mckesson_renews_pharmaceutical_distribution_agreement_with_cvs_caremark_090706-2/</loc>
		<lastmod>2009-07-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cardinal_health_renews_distribution_agreement_with_cvs_caremark_090706-2/</loc>
		<lastmod>2009-07-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofiaventis_unveils_lantus_study_results_090706-2/</loc>
		<lastmod>2009-07-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/avanir_completes_enrollment_in_zenvia_study_090706-2/</loc>
		<lastmod>2009-07-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/iavi_theraclone_expand_hiv_antibody_discovery_collaboration_090706-2/</loc>
		<lastmod>2009-07-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/coapt_systems_launches_hydrelle_090706-2/</loc>
		<lastmod>2009-07-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/oxigene_agrees_to_acquire_symphony_vida_090706-2/</loc>
		<lastmod>2009-07-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/celtic_pharma_to_invest_in_novacta_biosystems_090706-2/</loc>
		<lastmod>2009-07-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ikaria_signs_285m_drug_license_with_bioline_090706-2/</loc>
		<lastmod>2009-07-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/millipore_proteome_sciences_sign_licensing_agreement_090706-2/</loc>
		<lastmod>2009-07-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lilly_receives_fourth_fda_approval_for_alimta_090706-2/</loc>
		<lastmod>2009-07-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/morphosys_secures_fullterm_strategic_alliance_with_novartis_090706-2/</loc>
		<lastmod>2009-07-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/precision_biosciences_provides_update_regarding_us_patent_office_action_090706-2/</loc>
		<lastmod>2009-07-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis_delivers_250_millionth_of_coartem_treatment_090706-2/</loc>
		<lastmod>2009-07-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/actelion_tracleer_receives_eu_approval_for_pediatric_formulation_090706-2/</loc>
		<lastmod>2009-07-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/shire_files_treatment_protocol_for_gaucher_disease_090706-2/</loc>
		<lastmod>2009-07-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/natus_medical_acquires_hawaii_medical_090706-2/</loc>
		<lastmod>2009-07-05T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kdh_systems_launches_automated_clinical_trial_patient_recruitment_solution_090707-2/</loc>
		<lastmod>2009-07-06T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/therapyedge_right_to_care_launch_the_therapyedge_090707-2/</loc>
		<lastmod>2009-07-06T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kofax_provides_edco_with_distributed_capture_solution_090707-2/</loc>
		<lastmod>2009-07-06T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nxp_siemens_collaborate_on_rfid_innovation_090707-2/</loc>
		<lastmod>2009-07-06T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/european_commission_approves_boehringer_ingelheims_viramune_090706-2/</loc>
		<lastmod>2009-07-06T14:42:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pharmasset_nominates_psi938_as_development_candidate_for_hcv_090707-2/</loc>
		<lastmod>2009-07-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/essilor_forms_new_strategic_partnerships_090707-2/</loc>
		<lastmod>2009-07-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/synergy_pharmaceuticals_raises_709m_for_sp304_trial_090707-2/</loc>
		<lastmod>2009-07-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/repros_therapeutics_provides_update_on_proellex_090707-2/</loc>
		<lastmod>2009-07-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/emea_approves_cell_therapeutics_september_meeting_request_for_maa_090707-2/</loc>
		<lastmod>2009-07-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pluristem_initiates_phasei_cli_trial_090707-2/</loc>
		<lastmod>2009-07-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mylan_receives_fda_approval_for_bicalutamide_090707-2/</loc>
		<lastmod>2009-07-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lundbeck_acquires_all_shares_of_lifehealth_090707-2/</loc>
		<lastmod>2009-07-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/neugenesis_path_sign_collaboration_agreement_090707-2/</loc>
		<lastmod>2009-07-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lundbeck_acquires_neuronicon_090707-2/</loc>
		<lastmod>2009-07-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/imedicor_partners_mmc_for_global_video_library_of_medicine_090707-2/</loc>
		<lastmod>2009-07-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/humana_bg_medicine_enroll_over_6800_participants_090707-2/</loc>
		<lastmod>2009-07-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amgen_presents_positive_result_for_phaseiii_denosumab_trial_090707-2/</loc>
		<lastmod>2009-07-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/absorption_systems_acquires_perry_scientific_090707-2/</loc>
		<lastmod>2009-07-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gtx_initiates_phase_i_prostate_cancer_trial_090707-2/</loc>
		<lastmod>2009-07-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hyperion_receives_special_protocol_assessment_approval_from_fda_090707-2/</loc>
		<lastmod>2009-07-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/rexahn_completes_patient_enrollment_in_serdaxin_090707-2/</loc>
		<lastmod>2009-07-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aryx_reports_data_for_phase_23_tecarfarin_trial_090707-2/</loc>
		<lastmod>2009-07-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/canbas_takeda_initiate_phaseii_cancer_trials_090707-2/</loc>
		<lastmod>2009-07-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astellas_receives_approval_for_prograf_in_japan_090707-2/</loc>
		<lastmod>2009-07-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/drsi_launches_drsi_restore_energy_for_diabetics_090707-3/</loc>
		<lastmod>2009-07-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/access_thiarabine_demonstrates_efficacy_in_rheumatoid_arthritis_trial_090707-3/</loc>
		<lastmod>2009-07-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/press_ganey_to_open_branch_in_boston_090707-3/</loc>
		<lastmod>2009-07-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/presidio_selects_ppi461_as_clinical_candidate_hcv_program_090707-2/</loc>
		<lastmod>2009-07-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lexicon_initiates_phaseii_clinical_trial_for_carcinoid_syndrome_090707-2/</loc>
		<lastmod>2009-07-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/peplin_completes_enrollment_in_phaseiii_clinical_trials_090707-2/</loc>
		<lastmod>2009-07-06T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/galapagos_delivers_second_preclinical_candidate_in_alliance_with_gsk_090707-2/</loc>
		<lastmod>2009-07-07T16:32:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kineta_acquires_drug_candidates_from_airmid_090707-2/</loc>
		<lastmod>2009-07-07T16:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/celgene_files_new_drug_application_filing_for_revlimid_in_japan_090707-2/</loc>
		<lastmod>2009-07-07T17:13:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/king_pharmaceuticals_provides_update_on_remoxy_090707-2/</loc>
		<lastmod>2009-07-07T17:23:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk_presents_efficacy_data_for_cervarix_trial_090707-2/</loc>
		<lastmod>2009-07-07T17:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bayer_schering_submits_new_drug_application_for_oral_contraceptive_090708-2/</loc>
		<lastmod>2009-07-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cytheris_receives_uspto_notice_of_allowance_for_cyt107_090708-2/</loc>
		<lastmod>2009-07-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/marc_grossman_files_lawsuit_against_matrixx_090708-2/</loc>
		<lastmod>2009-07-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/japanese_ministry_of_health_approves_novartis_rasilez_090708-2/</loc>
		<lastmod>2009-07-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca_to_initiate_phaseiib_study_for_azd3480_090708-2/</loc>
		<lastmod>2009-07-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/repros_amends_license_agreement_with_nih_090708-2/</loc>
		<lastmod>2009-07-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/funxional_therapeutics_completes_phase_i_trial_of_antiinflammatory_drug_090708-2/</loc>
		<lastmod>2009-07-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dor_biopharma_receives_european_patent_for_drug_delivery_technology_090708-2/</loc>
		<lastmod>2009-07-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/watson_receives_fda_approval_for_fruit_cinnamon_flavored_nicotine_gums_090708-2/</loc>
		<lastmod>2009-07-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/wyeth_takeda_receive_japanese_approval_for_enbrel_090708-2/</loc>
		<lastmod>2009-07-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alpharx_reports_positive_preclinical_data_for_gai122_090708-2/</loc>
		<lastmod>2009-07-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_accepts_snda_for_eisais_dacogen_090708-2/</loc>
		<lastmod>2009-07-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/salvat_signs_licensing_agreement_with_wraser_pharmaceuticals_090708-2/</loc>
		<lastmod>2009-07-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biogen_idec_receives_fast_track_designation_for_multiple_sclerosis_drug_090708-2/</loc>
		<lastmod>2009-07-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/array_reports_topline_results_in_two_phasei_clinical_trials_090708-2/</loc>
		<lastmod>2009-07-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alnylam_joins_gsk_in_patent_pool_for_neglected_tropical_diseases_090708-2/</loc>
		<lastmod>2009-07-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/transdel_completes_enrollment_in_phaseiii_pain_trial_090708-2/</loc>
		<lastmod>2009-07-07T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chattem_reports_increase_in_q2_revenue_090709-2/</loc>
		<lastmod>2009-07-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bioheart_completes_series_d_financing_090709-2/</loc>
		<lastmod>2009-07-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chempartner_agios_expand_drug_discovery_research_collaboration_090709-2/</loc>
		<lastmod>2009-07-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/angiochem_receives_us_patent_for_angiopep2_090709-2/</loc>
		<lastmod>2009-07-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bioalliance_receives_european_approval_for_loramyc_tablet_090709-2/</loc>
		<lastmod>2009-07-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/stem_cell_issues_patents_in_india_090709-2/</loc>
		<lastmod>2009-07-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cadila_launches_joint_venture_with_novavax_in_india_090709-2/</loc>
		<lastmod>2009-07-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cardiodynamics_posts_net_loss_of_14_million_in_q2_fiscal_2009_090709-2/</loc>
		<lastmod>2009-07-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/revance_reports_efficacy_for_botulinum_toxin_type_a_090709-2/</loc>
		<lastmod>2009-07-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/scheringplough_receives_marketing_approval_for_remeron_in_japan_090709-2/</loc>
		<lastmod>2009-07-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bayer_signs_distribution_agreement_with_bioton_090709-2/</loc>
		<lastmod>2009-07-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sciele_terminates_merger_agreement_with_victory_pharma_090709-2/</loc>
		<lastmod>2009-07-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer_to_appeal_canadian_federal_court_decision_on_norvasc_patent_090709-2/</loc>
		<lastmod>2009-07-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/osmetech_gets_fda_clearance_for_cystic_fibrosis_genotyping_test_090709-2/</loc>
		<lastmod>2009-07-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biotime_signs_stem_cell_comarketing_agreement_with_millipore_090709-2/</loc>
		<lastmod>2009-07-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/covidien_initiates_voluntary_recall_of_sodium_chromate_cr51_injection_090709-2/</loc>
		<lastmod>2009-07-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/allon_provides_results_for_phaseii_schizophrenia_trial_090709-2/</loc>
		<lastmod>2009-07-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sciele_launches_ulesfia_lotion_090709-2/</loc>
		<lastmod>2009-07-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medarex_lonza_sign_collaboration_agreement_090709-2/</loc>
		<lastmod>2009-07-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pharmathene_sparvax_completes_fda_regulatory_strategy_review_090709-2/</loc>
		<lastmod>2009-07-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biotek_instruments_appoints_millennium_science_as_new_zealand_distributor_090709-2/</loc>
		<lastmod>2009-07-08T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/baseclear_to_bundle_illumina_data_with_clc_bios_software_090709-2/</loc>
		<lastmod>2009-07-09T08:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merge_healthcare_releases_new_surgery_management_system_090709-2/</loc>
		<lastmod>2009-07-09T08:16:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/healthport_signs_rac_software_deal_with_resurrection_090710-2/</loc>
		<lastmod>2009-07-09T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/icon_acquires_veeda_laboratories_090709-2/</loc>
		<lastmod>2009-07-09T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/who_grants_prequalification_to_gsk_cervarix_090709-2/</loc>
		<lastmod>2009-07-09T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/spectrum_pharmaceuticals_replies_to_fda_complete_response_letter_090709-2/</loc>
		<lastmod>2009-07-09T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/rigel_reports_positive_results_for_phase_2b_ra_trial_090709-2/</loc>
		<lastmod>2009-07-09T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amarin_reaches_special_protocol_assessment_agreement_with_fda_090709-2/</loc>
		<lastmod>2009-07-09T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dow_expands_capacity_of_shac_catalyst_for_polypropylene_090709-2/</loc>
		<lastmod>2009-07-09T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lsr_enters_into_merger_agreement_with_lion_holdings_090709-2/</loc>
		<lastmod>2009-07-09T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck__co_portola_sign_worldwide_license_agreement_090709-2/</loc>
		<lastmod>2009-07-09T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amylin_reports_positive_results_for_obesity_study_090709-2/</loc>
		<lastmod>2009-07-09T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca_terminates_license_agreement_with_map_pharmaceuticals_090709-2/</loc>
		<lastmod>2009-07-09T13:46:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/congressional_aides_warn_permanent_site_security_unlikely_this_year_090709-2/</loc>
		<lastmod>2009-07-09T15:51:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/awareness_key_to_preventing_theft_and_diversion_of_products_090709-2/</loc>
		<lastmod>2009-07-09T16:01:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lilly_receives_european_approval_for_alimta_090710-2/</loc>
		<lastmod>2009-07-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/innexus_genhelix_sign_letter_of_intent_090710-2/</loc>
		<lastmod>2009-07-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medtronic_recalls_paradigm_quickset_infusion_sets_in_us_090710-2/</loc>
		<lastmod>2009-07-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/epicept_initiates_postapproval_clinical_study_with_ceplene_090710-2/</loc>
		<lastmod>2009-07-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mentor_capital_acquires_20_stake_of_quantum_immunologics_090710-2/</loc>
		<lastmod>2009-07-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cardinal_health_to_spinoff_carefusion_090710-2/</loc>
		<lastmod>2009-07-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amarillo_completes_enrollment_in_influenza_phase_2_clinical_trial_090710-2/</loc>
		<lastmod>2009-07-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/addex_achieves_second_milestone_in_parkinson_disease_090710-2/</loc>
		<lastmod>2009-07-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bioniche_endo_pharmaceuticals_sign_licensing_agreement_for_urocidin_090710-2/</loc>
		<lastmod>2009-07-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aurobindo_receives_approval_for_fosinopril_sodium_hydrochlorothiazide_tablets_090710-2/</loc>
		<lastmod>2009-07-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vertex_to_sell_rights_of_european_milestone_payments_for_telaprevir_090710-2/</loc>
		<lastmod>2009-07-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/forest_laboratories_lundbeck_sign_settlement_agreement_with_sun_caraco_090710-2/</loc>
		<lastmod>2009-07-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bayer_vital_to_launch_omeprazole_in_germany_090710-2/</loc>
		<lastmod>2009-07-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gaster_shows_effectiveness_in_prevention_of_peptic_ulcers_090710-2/</loc>
		<lastmod>2009-07-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/glenmark_to_launch_fosinopril_sodium_hydrochlorothiazide_in_us_090710-2/</loc>
		<lastmod>2009-07-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/celesio_acquires_majority_stake_in_panpharma_090710-2/</loc>
		<lastmod>2009-07-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dharma_therapeutics_idds_shows_desired_results_090710-2/</loc>
		<lastmod>2009-07-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/johnson__johnson_completes_acquisition_of_cougar_090710-2/</loc>
		<lastmod>2009-07-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/daiichi_sankyo_lilly_obtains_fda_approval_for_effient_090710-2/</loc>
		<lastmod>2009-07-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hst_global_reports_termination_of_agreement_090710-2/</loc>
		<lastmod>2009-07-09T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_approves_effient_tablets_to_reduce_the_risk_of_blood_clots_090710-2/</loc>
		<lastmod>2009-07-10T16:17:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ridge_diagnostics_receives_202500_loan_from_biotech_center_090712-2/</loc>
		<lastmod>2009-07-11T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/finesse_solutions_enters_development_agreement_with_biogen_idec_090713-2/</loc>
		<lastmod>2009-07-12T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/phase_forward_edc_solution_has_been_utilized_in_more_than_3000_live_or_completed_trials_090713-2/</loc>
		<lastmod>2009-07-12T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/microchip_technology_introduces_new_8bit_pic_microcontrollers_090713-2/</loc>
		<lastmod>2009-07-12T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/perrigo_receives_fda_approval_to_market_nicotine_lozenges_090713-2/</loc>
		<lastmod>2009-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/macrogenics_initiates_phase_2_paradigm_trial_090713-2/</loc>
		<lastmod>2009-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sunesis_obtains_milestone_payment_from_biogen_idec_090713-2/</loc>
		<lastmod>2009-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/baxter_flamel_sign_collaboration_agreement_090713-2/</loc>
		<lastmod>2009-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/humanetics_reports_positive_results_for_phase_iia_alzheimers_trial_090713-2/</loc>
		<lastmod>2009-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_approves_teva_pharmaceutical_plan_b_onestep_emergency_contraceptive_090713-2/</loc>
		<lastmod>2009-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ivax_signs_distribution_agreement_with_augurix_090713-2/</loc>
		<lastmod>2009-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/axogen_begins_full_distribution_of_avance_nerve_graft_090713-2/</loc>
		<lastmod>2009-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/elan_transition_therapeutics_present_phase_1_clinical_trial_results_for_elnd005_090713-2/</loc>
		<lastmod>2009-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/inovio_h1n1_vaccine_shows_optimum_response_against_swine_flu_090713-2/</loc>
		<lastmod>2009-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cytrx_inno206_demonstrates_tumor_shrinkage_090713-2/</loc>
		<lastmod>2009-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bayer_florbetaben_shows_positive_results_090713-2/</loc>
		<lastmod>2009-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tarceva_shows_overall_survival_in_phase_iii_study_090713-2/</loc>
		<lastmod>2009-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/socma_commends_senate_for_extending_chemical_security_standards_for_one_year_090713-2/</loc>
		<lastmod>2009-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sirius_collaborates_with_assistance_publiquehopitaux_de_paris_090713-2/</loc>
		<lastmod>2009-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abraxis_completes_enrollment_in_phase_iii_abraxane_study_090713-2/</loc>
		<lastmod>2009-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ocls_signs_marketing_agreement_with_oroscience_090713-2/</loc>
		<lastmod>2009-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/iguardcom_signs_agreement_with_microsoft_healthvault_090713-2/</loc>
		<lastmod>2009-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biomarin_completes_enrollment_for_phase_iii_galns_trial_090713-2/</loc>
		<lastmod>2009-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medarex_initiates_phase_2_diabetes_trial_090713-2/</loc>
		<lastmod>2009-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/synexus_enrolls_patients_for_hypertension_study_090713-2/</loc>
		<lastmod>2009-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/axogen_acquires_distribution_rights_for_avance_nerve_graft_090713-2/</loc>
		<lastmod>2009-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbott_collaborates_on_molecular_diagnostic_test_with_gsk_090713-2/</loc>
		<lastmod>2009-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/rexahn_krict_form_licensing_partnership_090713-2/</loc>
		<lastmod>2009-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amag_launches_feraheme_injection_in_us_090713-2/</loc>
		<lastmod>2009-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda_accepts_victory_mgx006_for_review_090713-2/</loc>
		<lastmod>2009-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cornerstone_therapeutics_signs_asset_purchase_agreement_with_oscient_090713-2/</loc>
		<lastmod>2009-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/recordati_signs_license_agreement_with_amdipharm_090713-2/</loc>
		<lastmod>2009-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medicinova_proposes_final_protocol_for_phase_ii_asthma_trial_090713-2/</loc>
		<lastmod>2009-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/adaltis_receives_order_from_quebec_superior_court_establishing_claims_process_090713-2/</loc>
		<lastmod>2009-07-12T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/immucor_establishes_product_surveillance_and_improvement_department_090713-2/</loc>
		<lastmod>2009-07-13T12:28:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novimmune_selects_medidata_solutions_trial_planning_products_090714-2/</loc>
		<lastmod>2009-07-13T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/imany_s_government_pricing_to_be_processed_by_graceaway_pharmaceuticals_090714-2/</loc>
		<lastmod>2009-07-13T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sunquest_unveils_new_release_on_patient_safety_efficiency_workflow_090714-2/</loc>
		<lastmod>2009-07-13T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/maxygen_presents_positive_results_from_breast_cancer_study_090714-2/</loc>
		<lastmod>2009-07-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/johnson__johnson_reports_q209_results_090714-2/</loc>
		<lastmod>2009-07-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/irinotecan_available_in_six_eu_countries_on_patent_expiry_090714-2/</loc>
		<lastmod>2009-07-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/xoma_reports_positive_results_for_phase_1_diabetes_trial_090714-2/</loc>
		<lastmod>2009-07-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/watson_receives_complete_response_letter_for_trelstar_from_fda_090714-2/</loc>
		<lastmod>2009-07-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biomet_reports_net_loss_for_fiscal_2009_090714-2/</loc>
		<lastmod>2009-07-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/noven_signs_merger_agreement_with_hisamitsu_090714-2/</loc>
		<lastmod>2009-07-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/inspiration_biopharmaceuticals_releases_safety_data_for_ib1001_090714-2/</loc>
		<lastmod>2009-07-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alda_receives_us_patent_for_t36_090714-2/</loc>
		<lastmod>2009-07-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amexdrug_launches_alternative_pain_relievers_090714-2/</loc>
		<lastmod>2009-07-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/onset_therapeutics_launches_hylatopic_emollient_foam_090714-2/</loc>
		<lastmod>2009-07-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/keryx_initiates_phase_1_study_for_perifosine_090714-2/</loc>
		<lastmod>2009-07-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/canfite_to_initiate_phase_iii_hepatitis_c_trial_090714-2/</loc>
		<lastmod>2009-07-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/noven_reports_positive_phase_2_results_for_mesafem_090714-2/</loc>
		<lastmod>2009-07-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/wyeth_receives_first_approval_for_prevenar_13_090714-2/</loc>
		<lastmod>2009-07-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/yissum_licenses_stem_cell_technologies_to_theracell_090714-2/</loc>
		<lastmod>2009-07-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/seracare_life_sciences_unveils_suite_of_products_in_genetic_controls_portfolio_090714-2/</loc>
		<lastmod>2009-07-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sartorius_stedim_biotech_partners_with_safc_biosciences_090714-2/</loc>
		<lastmod>2009-07-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/wyeth_unit_launches_genderagespecific_adult_multivitamin_line_090714-2/</loc>
		<lastmod>2009-07-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/immunovaccine_signs_licenses_agreement_with_immunotope_090714-2/</loc>
		<lastmod>2009-07-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bayer_schering_provides_update_on_rivaroxaban_090714-2/</loc>
		<lastmod>2009-07-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/halozyme_initiates_patient_dosing_in_phase_2_diabetes_trial_090714-2/</loc>
		<lastmod>2009-07-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biotech_to_initiate_clinical_trial_for_shban_antiviral_hand_sanitizer_090714-2/</loc>
		<lastmod>2009-07-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/quantum_immunologics_initiates_phase_iii_breast_cancer_trial_090714-2/</loc>
		<lastmod>2009-07-13T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vidacare_raises_76m_in_private_equity_financing_090714-2/</loc>
		<lastmod>2009-07-14T02:25:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/beta_release_of_v30_of_openclinica_clinical_trials_software_090714-2/</loc>
		<lastmod>2009-07-14T09:48:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biowa_signs_license_agreement_with_merck_090715-2/</loc>
		<lastmod>2009-07-14T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/baptist_health_implements_central_logics_forefront_transfer_solution_090715-2/</loc>
		<lastmod>2009-07-14T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ivax_signs_amended_distribution_agreement_with_immco_090715-2/</loc>
		<lastmod>2009-07-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/watson_files_abbreviated_new_drug_application_for_generic_sanctura_xr_090715-2/</loc>
		<lastmod>2009-07-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/array_biopharma_advances_mek_inhibitor_into_cancer_090715-2/</loc>
		<lastmod>2009-07-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/scheringplough_extends_phase_ii_study_with_vicriviroc_090715-2/</loc>
		<lastmod>2009-07-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/advitech_raises_34m_in_financing_090715-2/</loc>
		<lastmod>2009-07-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbott_records_positive_second_quarter_results_090715-2/</loc>
		<lastmod>2009-07-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/celesio_takes_over_laboratoria_flandria_090715-2/</loc>
		<lastmod>2009-07-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cornerstone_submits_regulatory_filing_for_extendedrelease_antitussive_product_090715-2/</loc>
		<lastmod>2009-07-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dow_ibm_pair_up_for_it_services_agreement_090715-2/</loc>
		<lastmod>2009-07-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/baxter_halozyme_completes_patient_enrollment_for_phaseiii_gammagard_liquid_trial_090715-2/</loc>
		<lastmod>2009-07-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/centocor_ortho_biotech_replies_to_fda_opinion_on_doxil_090715-2/</loc>
		<lastmod>2009-07-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/centocor_ortho_response_to_fda_opinion_on_trabectedin_090715-2/</loc>
		<lastmod>2009-07-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nature__health_recalls_six_male_enhancement_products_marketed_as_dietary_supplements_090715-2/</loc>
		<lastmod>2009-07-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck_scheringplough_resolve_investigation_under_state_consumer_protection_statutes_090715-2/</loc>
		<lastmod>2009-07-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cadence_reports_priority_review_acceptance_of_nda_submission_for_acetavance_090715-2/</loc>
		<lastmod>2009-07-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/targacept_shows_positive_results_for_phase_2b_clinical_trial_of_tc5214_090715-2/</loc>
		<lastmod>2009-07-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/quantum_immunologics_initiates_breast_cancer_trials_090715-2/</loc>
		<lastmod>2009-07-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/paion_to_restart_phase_iia_study_phase_ib_of_cns_7065_090715-2/</loc>
		<lastmod>2009-07-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/taro_receives_us_patent_for_ovide_090715-2/</loc>
		<lastmod>2009-07-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sabic_launches_yansab_complex_at_yanbu_090715-2/</loc>
		<lastmod>2009-07-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/polymedix_obtains_us_patent_for_angiogenesis_inhibitor_compounds_090715-2/</loc>
		<lastmod>2009-07-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/envivo_completes_phase_ibiia_trial_of_evp6124_090715-2/</loc>
		<lastmod>2009-07-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer_presents_phase_1_result_for_alzheimers_study_090715-2/</loc>
		<lastmod>2009-07-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/advtx_presents_new_treatment_for_bleeding_after_nuclear_exposure_090715-2/</loc>
		<lastmod>2009-07-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/america_stem_cell_awarded_25m_by_texas_emerging_technology_fund_090715-2/</loc>
		<lastmod>2009-07-14T18:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/velos_releases_software_to_support_cancer_centers_with_new_workflow_content_090716-2/</loc>
		<lastmod>2009-07-15T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biodelivery_meda_receive_fda_approval_for_onsolis_090716-2/</loc>
		<lastmod>2009-07-15T13:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/champions_biotech_collaborates_with_docoop_technologies_090716-2/</loc>
		<lastmod>2009-07-15T13:00:00+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->